<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Essays Biochem</journal-id><journal-id journal-id-type="iso-abbrev">Essays Biochem</journal-id><journal-id journal-id-type="publisher-id">ebc</journal-id><journal-title-group><journal-title>Essays in Biochemistry</journal-title></journal-title-group><issn pub-type="ppub">0071-1365</issn><issn pub-type="epub">1744-1358</issn><publisher><publisher-name>Portland Press Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10500201</article-id><article-id pub-id-type="pmid">36876884</article-id><article-id pub-id-type="doi">10.1042/EBC20220222</article-id><article-id pub-id-type="publisher-id">EBC20220222</article-id><article-categories><subj-group subj-group-type="heading"><subject>Biotechnology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology</subject></subj-group><subj-group subj-group-type="toc-heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>Gliotoxin and related metabolites as zinc chelators: implications and exploitation to overcome antimicrobial resistance</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Jones</surname><given-names>Gary</given-names></name></contrib><contrib contrib-type="editor"><name><surname>Usher</surname><given-names>Jane</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Downes</surname><given-names>Shane&#x000a0;G.</given-names></name><xref rid="AFF1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Doyle</surname><given-names>Sean</given-names></name><xref rid="AFF1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Jones</surname><given-names>Gary&#x000a0;W.</given-names></name><xref rid="AFF2" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6545-1978</contrib-id><name><surname>Owens</surname><given-names>Rebecca&#x000a0;A.</given-names></name><email>rebecca.owens@mu.ie</email><xref rid="AFF1" ref-type="aff"/><xref rid="COR1" ref-type="corresp"/></contrib></contrib-group><aff id="AFF1"><label>1</label>Department of Biology, Maynooth University, Maynooth, Co. Kildare, Ireland</aff><aff id="AFF2"><label>2</label>Centre for Biomedical Science Research, School of Health, Leeds Beckett University, Leeds LS1 3HE, U.K.</aff><author-notes><corresp id="COR1"><bold>Correspondence:</bold> Rebecca A. Owens (<email>rebecca.owens@mu.ie</email>)</corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-09-13"><day>13</day><month>9</month><year>2023</year></pub-date><volume>67</volume><issue>5</issue><issue-title>Fungal Biochemistry</issue-title><fpage>769</fpage><lpage>780</lpage><history><date date-type="received"><day>21</day><month>12</month><year>2022</year></date><date date-type="rev-recd"><day>03</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>06</day><month>2</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 The Author(s).</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CC BY)</ext-link>.</license-p></license></permissions><self-uri xlink:href="ebc-67-ebc20220222.pdf"/><abstract><title>Abstract</title><p>Antimicrobial resistance (AMR) is a major global problem and threat to humanity. The search for new antibiotics is directed towards targeting of novel microbial systems and enzymes, as well as augmenting the activity of pre-existing antimicrobials. Sulphur-containing metabolites (e.g., auranofin and bacterial dithiolopyrrolones [e.g., holomycin]) and Zn<sup>2+</sup>-chelating ionophores (PBT2) have emerged as important antimicrobial classes. The sulphur-containing, non-ribosomal peptide gliotoxin, biosynthesised by <italic toggle="yes">Aspergillus fumigatus</italic> and other fungi exhibits potent antimicrobial activity, especially in the dithiol form (dithiol gliotoxin; DTG). Specifically, it has been revealed that deletion of the enzymes gliotoxin oxidoreductase GliT, <italic toggle="yes">bis</italic>-thiomethyltransferase GtmA or the transporter GliA dramatically sensitise <italic toggle="yes">A. fumigatus</italic> to gliotoxin presence. Indeed, the double deletion strain <italic toggle="yes">A. fumigatus</italic> &#x00394;<italic toggle="yes">gliT</italic>&#x00394;<italic toggle="yes">gtmA</italic> is especially sensitive to gliotoxin-mediated growth inhibition, which can be reversed by Zn<sup>2+</sup> presence. Moreover, DTG is a Zn<sup>2+</sup> chelator which can eject zinc from enzymes and inhibit activity. Although multiple studies have demonstrated the potent antibacterial effect of gliotoxin, no mechanistic details are available. Interestingly, reduced holomycin can inhibit metallo-&#x003b2;-lactamases. Since holomycin and gliotoxin can chelate Zn<sup>2+</sup>, resulting in metalloenzyme inhibition, we propose that this metal-chelating characteristic of these metabolites requires immediate investigation to identify new antibacterial drug targets or to augment the activity of existing antimicrobials. Given that (i) gliotoxin has been shown <italic toggle="yes">in vitro</italic> to significantly enhance vancomycin activity against <italic toggle="yes">Staphylococcus aureus</italic>, and (ii) that it has been independently proposed as an ideal probe to dissect the central &#x02018;Integrator&#x02019; role of Zn<sup>2+</sup> in bacteria &#x02013; we contend such studies are immediately undertaken to help address AMR.</p></abstract><kwd-group><kwd>AMR</kwd><kwd>antimicrobial resistance</kwd><kwd>gliotoxin</kwd><kwd>Nutritional immunity</kwd><kwd>quantitiative proteomics</kwd><kwd>zinc</kwd></kwd-group><counts><page-count count="12"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><sec id="sec1-1"><title>Antimicrobial resistance</title><p>Antimicrobial resistance (AMR) has been identified by multiple international agencies and governments as one of the major risks to human health in the next 50 years, and beyond [<xref rid="B1" ref-type="bibr">1</xref>]. Moreover, it is estimated that the global economic loss associated with AMR, over the next 40 years, could be as high as $3 trillion [<xref rid="B2" ref-type="bibr">2</xref>]. The problem of AMR is twofold: (i) bacteria have acquired resistance to conventional antibiotics (e.g., carbapenems, aminoglycosides, fluoroquinolones and vancomycin) and (ii) there is a shortage of novel and effective antibiotics, and new targets &#x02013; although this is slowly beginning to be addressed [<xref rid="B3" ref-type="bibr">3</xref>]. Methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA) accounts for up to 70% of <italic toggle="yes">S. aureus</italic> infections in clinical settings, is responsible for most invasive infections caused by AMR bacteria and is associated with a 14% fatality rate [<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>]. Vancomycin-resistant enterococci (VRE) consist mainly of <italic toggle="yes">Enterococcus faecium</italic> and <italic toggle="yes">faecalis</italic>, and vancomycin is considered the antibiotic of last resort. VRE have become common in many hospitals throughout the world and, when established, cannot be eradicated [<xref rid="B6" ref-type="bibr">6</xref>]. Indeed, most severe VRE infections require combination therapy because when used alone, most antimicrobial agents only effect bacteriostasis and do not clear infections. <italic toggle="yes">E. faecium</italic> along with <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Klebsiella pneumoniae</italic>, <italic toggle="yes">Acinetobacter baumannii, Pseudomonas aeruginosa</italic> and <italic toggle="yes">Enterobacter spp</italic>. comprise the priority so-called &#x02018;<italic toggle="yes">ESKAPE</italic>&#x02019; group of bacteria. They can all cause life-threatening nosocomial infections amongst critically ill and immunocompromised individuals and exhibit potential drug resistance mechanisms [<xref rid="B7" ref-type="bibr">7</xref>]. It is therefore essential that new strategies are considered and deployed to overcome AMR [<xref rid="B8" ref-type="bibr">8</xref>].</p></sec><sec id="sec1-2"><title>New directions to overcome AMR</title><sec id="sec1-2-1"><title>Emerging antimicrobials</title><p>The FDA-approved organogold, a <italic toggle="yes">sulphur</italic>-containing drug auranofin, has been shown to be a potent inhibitor of bacterial thioredoxin reductase TrxR, and therefore disrupts the redox balance in <italic toggle="yes">Mycobacterium tuberculosis</italic> [<xref rid="B9" ref-type="bibr">9</xref>]. Auranofin causes bacterial cell death, and has shown promise in <italic toggle="yes">in vivo</italic> efficacy studies in a murine model of systemic MRSA infection. Thus, it is an emerging candidate for antibacterial therapy which disrupts redox control [<xref rid="B9" ref-type="bibr">9</xref>]. Another class of thiol-containing metabolites, the bacterial dithiolopyrrolones (DTPs) (e.g., holomycin, thiolutin and thiomarinol B) are effective antimicrobial agents &#x02013; yet their mode of action, apart from recently identified metal chelation properties, remains very poorly understood [<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref>]. The hydroxyquinoline ionophore PBT2 enables zinc transport across biological membranes which results in altered intracellular zinc homeostasis [<xref rid="B12" ref-type="bibr">12</xref>]. Although PBT2 was abandoned as a therapeutic for Alzheimer&#x02019;s and Huntington&#x02019;s diseases, it showed a good safety profile. Relevantly, in 2018 it was shown that PBT2-Zn destabilizes key cellular homeostasis pathways involved in bacterial antibiotic resistance mechanisms and <italic toggle="yes">in vivo</italic> dramatically re-sensitised VRE to vancomycin, as well as enhancing erythromycin and methicillin sensitivity in other species [<xref rid="B12" ref-type="bibr">12</xref>]. This elegant work has clearly indicated disrupted zinc homeostasis as a new direction in overcoming AMR. Indeed, it was subsequently shown [<xref rid="B13" ref-type="bibr">13</xref>] that PBT2 is a Zn<sup>2+</sup>/H<sup>+</sup> ionophore which exhibits bactericidal activity in <italic toggle="yes">Streptococcus uberis</italic> through intracellular zinc toxicity, resulting in reactive oxygen species (ROS) accumulation and dysregulated Mn<sup>2+</sup> homeostasis, ultimately causing bacterial hypersensitivity to oxidative stress. PBT2 has also been proposed as a potential therapeutic to treat infection with the biofilm-forming, Gram-negative anaerobic pathogen, <italic toggle="yes">Fusobacterium nucleatum</italic> [<xref rid="B14" ref-type="bibr">14</xref>] and it has also been shown to rescue tetracycline-class antibiotics in multi-drug resistant <italic toggle="yes">A. baumannii</italic> [<xref rid="B15" ref-type="bibr">15</xref>]. However, in addition to possible neurological interactions, PBT2 is not naturally occurring and is only available by chemical synthesis. This underpins the exploration of alternative zinc-chelating compounds of microbial origin, like the epipolythiodioxopiperazine (ETP) gliotoxin (GT) or derivatives to (i) disrupt intracellular zinc homeostasis, (ii) enhance ionophore-induced zinc and ROS dysregulation, (iii) rescue antibiotic sensitivity and (iv) identify new cellular systems as antimicrobial targets [<xref rid="B16" ref-type="bibr">16</xref>] (<xref rid="F1" ref-type="fig">Figure 1</xref>). Furthermore, like holomycin, the redox-active fungal metabolite, GT, has significant antimicrobial activity, possibly due to the zinc-chelating properties of the reduced form of GT [<xref rid="B17" ref-type="bibr">17&#x02013;20</xref>]. Although GT is likely unsuitable for direct usage as an antibacterial due to cytotoxicity towards animal cells, it has significant potential as a &#x02018;Pathfinder&#x02019; to identify susceptible molecular targets and potentially developing completely novel approaches to overcoming AMR in bacteria (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><title>Literature-based rationale to investigate the inhibitory effects of gliotoxin/dithiol gliotoxin (GT/DTG) against bacteria to help overcome antimicrobial resistance</title><p>GT/DTG inhibit bacterial growth and can also augment antibiotic activity. DTG, of fungal origin and with antifungal activity, is a zinc chelator and bacterial zinc homeostasis has been shown to be essential for growth and virulence. GT and holomycin are functional analogues, reduced holomycin and DTG inhibit specific zinc-metalloprotein activity and zinc ionophores exhibit antimicrobial activity and rescue antibiotic sensitivity. GT has independently been proposed as a probe for integrated bacterial zinc homeostasis systems with one carbon (1C) metabolism and ribosomal distribution [ <xref rid="B80" ref-type="bibr">80</xref>].</p></caption><graphic xlink:href="ebc-67-ebc20220222-g1" position="float"/></fig></sec><sec id="sec1-2-2"><title>GT biosynthesis, self-resistance and systems interactions in fungi</title><p>GT is a disulphide bridge-containing ETP, produced by <italic toggle="yes">Aspergillus fumigatus</italic> under zinc-limiting conditions, which can exist in oxidised, reduced and <italic toggle="yes">bis</italic>-thiomethylated (BmGT; bisdethiobis(methylthio)gliotoxin) forms [<xref rid="B21" ref-type="bibr">21&#x02013;24</xref>] (<xref rid="F2" ref-type="fig">Figure 2</xref>A). Interestingly, the non-ribosomal peptide GT can induce its own biosynthesis in <italic toggle="yes">A. fumigatus</italic> [<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>], and its ability to chelate zinc is reminiscent of siderophore-mediated iron chelation [<xref rid="B27" ref-type="bibr">27</xref>]. Significant advances have been made in our understanding of GT biosynthesis, including identification of the GT-encoding <italic toggle="yes">gli</italic> biosynthetic gene cluster which comprises 13 genes in <italic toggle="yes">A. fumigatus</italic>, GliZ transcription factor function, GliP non-ribosomal peptide synthetase characterization, GliG-mediated use of glutathione (GSH) as the sulphur source for biosynthetic intermediate sulphurization, GliT oxidoreductase (along with GliA an MFS transporter) as a self-resistance mechanism against GT, and GtmA (also termed TmtA) <italic toggle="yes">bis</italic>-thiomethyltransferase identification [<xref rid="B28" ref-type="bibr">28&#x02013;35</xref>]. The latter enzyme is non-cluster encoded and dissipates GT biosynthesis [<xref rid="B34" ref-type="bibr">34</xref>]. These discoveries have, in turn, informed on the biosynthetic mechanism of related ETP structures in other fungi (reviewed in [<xref rid="B23" ref-type="bibr">23</xref>]), and holomycin in bacteria [<xref rid="B36" ref-type="bibr">36</xref>] (<xref rid="F2" ref-type="fig">Figure 2</xref>B). Reciprocally, holomycin studies have informed advances in GT biosynthesis [<xref rid="B37" ref-type="bibr">37</xref>], as described below.</p><fig position="float" id="F2"><label>Figure 2</label><caption><title>Hypothetical model for gliotoxin/dithiol gliotoxin (GT/DTG) inhibition of bacterial growth</title><p>(<bold>A</bold>) Currently, it is unclear if GT or DTG-zinc chelate (DTG:Zn<sup>2+</sup>) is acquired by bacteria, and if other metals ions are capable of chelate formation with DTG. However, it is postulated that upon uptake, GT is reduced to DTG by cellular reductants (e.g., L-Cys, GSH, coenzyme A, etc.) followed by zinc chelation. Consequently, this may deplete intracellular zinc, disrupt intracellular zinc homeostasis or destabilise zinc metalloenzymes leading to growth inhibition. Altered intracellular proteome or increased abundance of zinc uptake systems may ensue, as has been observed in fungi [<xref rid="B22" ref-type="bibr">22</xref>]. GT addition to bacteria may also interfere with biofilm formation [<xref rid="B51" ref-type="bibr">51</xref>]. (<bold>B</bold>) Holomycin. (<bold>C</bold>) Reduced holomycin.</p></caption><graphic xlink:href="ebc-67-ebc20220222-g2" position="float"/></fig><p>Moreover, three important implications derive from the aforementioned, and related studies, on GT and other ETPs. Firstly, in fungi and animal cells, intracellular GSH can convert GT to reduced or dithiol gliotoxin (DTG) which may in turn (i) disrupt cellular redox homeostasis and (ii) chelate free zinc or eject zinc from metalloenzymes [<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B38" ref-type="bibr">38</xref>,<xref rid="B39" ref-type="bibr">39</xref>] (<xref rid="F2" ref-type="fig">Figure 2</xref>A). Secondly, GliT is essential to convert DTG to GT which is then effluxed from mycelia via GliA, or GtmA <italic toggle="yes">bis</italic>-thiomethylates DTG to BmGT to switch off GT biosynthesis [<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B40" ref-type="bibr">40</xref>,<xref rid="B41" ref-type="bibr">41</xref>]. Thirdly, DTG <italic toggle="yes">bis</italic>-thiomethylation requires 2 mol <italic toggle="yes">S</italic>-adenosyl methionine (SAM) per mol BmGT formed, in addition to forming 2 mol <italic toggle="yes">S</italic>-adenosyl homocysteine (SAH), and tethers the dissipation of GT biosynthesis to the fungal methyl-methionine cycle [<xref rid="B41" ref-type="bibr">41</xref>]. Capable of expression independently of the <italic toggle="yes">gli</italic> cluster, GliT activity prevents GtmA-mediated dysregulation of the cellular methyl-methionine cycle in <italic toggle="yes">A. fumigatus</italic> [<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B41" ref-type="bibr">41</xref>]. The absence of both <italic toggle="yes">gliT</italic> and <italic toggle="yes">gtmA</italic> hypersensitises the organism to exogenous GT, which can be reversed by zinc addition [<xref rid="B42" ref-type="bibr">42</xref>]. Indeed, given the essential nature of SAM for a plethora of cellular transmethylation reactions including, but not limited to, epigenetic regulation [<xref rid="B43" ref-type="bibr">43</xref>], and the potential inhibitory action of SAH on cellular methyltransferases [<xref rid="B44" ref-type="bibr">44</xref>], the metabolically catastrophic potential of dysregulating GliT-mediated control of GT/BmGT biosynthesis is only just becoming apparent. Further systems impacts of interfering with GT biosynthesis are emerging (i.e., aberrant zinc homeostasis [<xref rid="B22" ref-type="bibr">22</xref>]) and, surprisingly, we have shown that the biosynthesis of apparently unrelated natural products, like the powerful antioxidant ergothioneine, is influenced either by GT [<xref rid="B45" ref-type="bibr">45</xref>,<xref rid="B46" ref-type="bibr">46</xref>], or specific reactions within its biosynthetic pathway [<xref rid="B47" ref-type="bibr">47</xref>]. So, the activity of GT against fungi and animal cells is revealing new interactions within biological systems, including zinc homeostasis [<xref rid="B22" ref-type="bibr">22</xref>] as has been discussed elsewhere [<xref rid="B16" ref-type="bibr">16</xref>], and now merits consideration to identify new drug targets in bacteria (<xref rid="F2" ref-type="fig">Figure 2</xref>A).</p><p>Experimentally, quantitative proteomic analysis, and parallel RNAseq [<xref rid="B26" ref-type="bibr">26</xref>], allied to intracellular metabolite quantification, have uncovered hitherto unforeseen systems interactions between GT/BmGT biosynthesis, self-resistance, altered sulphur metabolism and zinc homeostasis in <italic toggle="yes">A. fumigatus</italic> [<xref rid="B48" ref-type="bibr">48</xref>]. In combination, this dissection of GT biosynthesis and self-resistance has led to the discovery of new aspects of fungal systems biology [<xref rid="B16" ref-type="bibr">16</xref>], and now underpins the concept of GT deployment to identify essential bacterial systems (e.g., those responsible for cellular metal ion homeostasis and methylation systems) and bacterial drug targets, the inhibition of which can lead to circumventing or overcoming AMR [<xref rid="B49" ref-type="bibr">49</xref>] (<xref rid="F1" ref-type="fig">Figure 1</xref>). Given that GT also exhibits significant antibacterial activity [<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B51" ref-type="bibr">51</xref>], of unknown mechanistic etiology but now hypothesised to involve interference with zinc homeostasis/metalloenzyme function and methylation, future molecular dissection of GT-mediated bacterial growth inhibition may reveal new avenues to identify new antibiotic targets, rescue antibiotic sensitivity and overcome AMR, in bacteria (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec1-2-3"><title>GT and holomycin equivalence</title><p>Quantitative proteomic approaches have been extensively used to dissect GT resistance and functionality in <italic toggle="yes">A. fumigatus</italic>, as well as its impact on cellular homeostasis, in fungi, and it has been revealed that DTG is a zinc chelator, which positions DTG as a Zn<sup>2+</sup>-metalloenzyme inhibitor [<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B34" ref-type="bibr">34</xref>]. In <italic toggle="yes">A. fumigatus</italic>, GT oxidoreductase GliT catalyses resistance to the reactive form of GT, DTG [<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B33" ref-type="bibr">33</xref>]. In addition, it has been demonstrated that GT <italic toggle="yes">bis</italic>-thiomethylation is mediated by <italic toggle="yes">bis</italic>-thiomethyltransferase GtmA which requires SAM as a co-substrate, to effect attenuation of GT biosynthesis [<xref rid="B34" ref-type="bibr">34</xref>]. While it is explicitly not conceptualised that GT can be exploited as an antibiotic, given that bacteria are sensitive to GT, it is essential to consider innovative exploitation of GT as a <italic toggle="yes">Pathfinder</italic> to identify new antibiotic targets and overcome AMR.</p><p>Thus, historical and emerging literature [<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B52" ref-type="bibr">52</xref>], the ground-breaking finding that DTG can eject Zn<sup>2+</sup> from metalloenzymes [<xref rid="B22" ref-type="bibr">22</xref>], plus emerging data and the functional equivalence between GT and holomycin, provides a convincing and urgent rationale for investigating the aforementioned bacterial sensitivity to GT as a novel and highly promising direction in the fight against AMR (<xref rid="F2" ref-type="fig">Figure 2</xref>). Studies on GT and bacterial holomycin biosynthesis and self-resistance, in <italic toggle="yes">A. fumigatus</italic> and <italic toggle="yes">Streptomyces clavuligerus</italic>, respectively, have occurred in parallel since 2010, with concepts reciprocally contributing to the respective field. For instance, the seminal discovery of <italic toggle="yes">gliT</italic>-mediated self-resistance against GT [<xref rid="B33" ref-type="bibr">33</xref>] was mirrored in the observation of <italic toggle="yes">hlmI</italic>-mediated self-protection against holomycin in <italic toggle="yes">S. clavuligerus</italic> [<xref rid="B37" ref-type="bibr">37</xref>]. The observation of <italic toggle="yes">bis</italic>-thiomethylated holomycin derivatives in <italic toggle="yes">S. clavuligerus</italic> &#x02206;<italic toggle="yes">hlmI</italic>, which was posited as a back-up self-resistance mechanism [<xref rid="B53" ref-type="bibr">53</xref>], preceded the discovery of GtmA-mediated gliotoxin <italic toggle="yes">bis</italic>-thiomethyltransferase in <italic toggle="yes">A. fumigatus</italic>. In the latter species, as noted above it has been demonstrated that GtmA primarily serves a negative regulatory biosynthetic, as opposed to self-protection, function [<xref rid="B34" ref-type="bibr">34</xref>]. The enzyme which mediates <italic toggle="yes">bis</italic>-thiomethylation of dithiol holomycin (<xref rid="F2" ref-type="fig">Figure 2</xref>C) remains to be discovered, thereby limiting holomycin use as a Pathfinder.</p><p>Holomycin biosynthesis is encoded by the <italic toggle="yes">hom</italic> gene cluster in the pathogen, <italic toggle="yes">Yersinia ruckeri</italic> [<xref rid="B54" ref-type="bibr">54</xref>]. However, the <italic toggle="yes">Y</italic>. <italic toggle="yes">ruckeri hom</italic> cluster lacks the <italic toggle="yes">hlmI</italic> self-resistance gene found in <italic toggle="yes">S. clavuligerus</italic>, and instead encodes a SAM-dependant RNA methyltransferase, termed <italic toggle="yes">hom12</italic>. Absence of <italic toggle="yes">hom12</italic> results in acquisition of holomycin sensitivity in <italic toggle="yes">Y</italic>. <italic toggle="yes">ruckeri</italic>, and Hom12 has been demonstrated to directly methylate RNA, which has resulted in the proposal that Hom12-mediated-RNA methylation is a novel self-resistance mechanism to facilitate holomycin production in bacteria lacking <italic toggle="yes">hlmI</italic> [<xref rid="B54" ref-type="bibr">54</xref>]. As yet, the exact nature of the RNA species which is methylated, and position(s) of methylation are unknown. Aminoglycoside, macrolide and lincosamide antibiotics inhibit bacterial protein synthesis by targeting RNA. Methylation also directly inhibits antibiotic function in bacteria [<xref rid="B55" ref-type="bibr">55</xref>]. Relevantly, the primary means of bacterial resistance to macrolide antibiotics is by post-transcriptional methylation of the 23S bacterial ribosomal RNA [<xref rid="B56" ref-type="bibr">56</xref>]. Moreover, RNA methylation may be deployed in certain antibiotic-producing bacteria to alter ribosome structure (via rRNA modification), thereby reducing the affinity for, and consequent activity of, the cognate antibiotic. Nascent self-protection and resistance mechanisms against holomycin clearly illuminate a biochemical link between antibiotic resistance and methylation. Consequently, it is evident that interference with cellular methylation in bacteria could disrupt the capacity of bacteria to exploit RNA methylation as an antibiotic resistance strategy. Thus, combinatorial chemoenzymatic approaches of using both GT exposure and <italic toggle="yes">in vivo</italic> GtmA activity to deplete cellular SAM levels in bacterial <italic toggle="yes">spp.</italic>, to assess if altered substrate availability for SAM-dependant RNA methyltransferases could prevent the development of resistance mechanisms mediated by RNA methylation are merited.</p></sec><sec id="sec1-2-4"><title>GT and zinc</title><p>GT contains an intramolecular disulphide bridge and can undergo intracellular chemical reduction, mediated by GSH, to DTG [<xref rid="B38" ref-type="bibr">38</xref>]. While GSH is not produced by all bacterial spp. that does not rule out GT reduction and thiol depletion as a means of GT-induced bacterial growth inhibition, since there are other naturally occurring thiols with similar functions. These include mycothiol (MSH), L-Cys, H<sub>2</sub>S, and coenzyme A [<xref rid="B57" ref-type="bibr">57</xref>], moreover, the primary thiol depends on the species in question, with GSH more evident in actinomycetes while non-actinomycetes spp. primarily produce MSH. Tris(2-carboxyethyl)phosphine (TCEP) and other reductants facilitate <italic toggle="yes">in vitro</italic> DTG formation from GT [<xref rid="B58" ref-type="bibr">58</xref>]. GT is produced by <italic toggle="yes">A. fumigatus</italic>, in what recent studies suggest is in a zinc-dependent manner [<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B59" ref-type="bibr">59</xref>]. DTG is a biosynthetic intermediate in the GT biosynthetic pathway and likely formed by GSH-mediated reduction of GT in <italic toggle="yes">A. fumigatus</italic>, however its presence is detrimental and two enzymes and a membrane transporter (GliT, GtmA and GliA) are present to effect its dismutation and secretion. Indeed, GT and other ETPs not only inhibit fungal growth but have been shown to inhibit the growth of multiple bacterial species [<xref rid="B60" ref-type="bibr">60</xref>,<xref rid="B61" ref-type="bibr">61</xref>] (<xref rid="T1" ref-type="table">Table 1</xref>) and also possibly prevent biofilm formation [<xref rid="B51" ref-type="bibr">51</xref>]. Mainly studied in fungal settings [<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B45" ref-type="bibr">45</xref>,<xref rid="B62" ref-type="bibr">62</xref>,<xref rid="B63" ref-type="bibr">63</xref>], there is limited research into the GT mechanism of action on bacterial species. Indeed, apart from a publication inferring interference with GSH levels, no mechanistic details have been forthcoming about how GT inhibits bacterial growth [<xref rid="B64" ref-type="bibr">64</xref>]. Interestingly, antibiotic (cefotaxime; CTX) resistance of <italic toggle="yes">K. pneumoniae</italic> has been overcome by thiol-mediated inhibition of zinc metallo-&#x003b2;-lactamase activity [<xref rid="B65" ref-type="bibr">65</xref>]. Specifically, L-Cys was identified as an endogenous zinc chelator, which rescued metallo-&#x003b2;-lactamase-secreting <italic toggle="yes">K. pneumoniae</italic> to CTX (<xref rid="F3" ref-type="fig">Figure 3</xref>).</p><fig position="float" id="F3"><label>Figure 3</label><caption><title>Thiol compounds inhibit MBL and re-sensitise bacteria to the antibiotic</title><p>Zinc-dependent metallo &#x003b2;-lactamases (MBL) are secreted by <italic toggle="yes">K. pneumoniae</italic> and hydrolyse cefotaxime antibiotic (CTX), which facilitates bacterial resistance to the antibiotic. Thiol compounds in culture media or urine (e.g., endogenous L-Cys or that produced by thioredoxin reductase activity on L-cystine) can either bind free zinc or inhibit MBL via zinc ejection and prevent MBL degradation of CTX. This re-sensitizes the bacteria to the antibiotic [<xref rid="B65" ref-type="bibr">65</xref>].</p></caption><graphic xlink:href="ebc-67-ebc20220222-g3" position="float"/></fig><p>Since our demonstration that GT-mediated growth inhibition of specific <italic toggle="yes">A. fumigatus</italic> mutants is substantially due to zinc chelation, depletion and possibly metalloenzyme inhibition, several publications have emerged focussing on the GT/Zn axis in <italic toggle="yes">A. fumigatus</italic>. However, here we go further and based on literature observations [<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B66" ref-type="bibr">66</xref>] and unpublished preliminary data, hypothesise that the potent zinc-chelating ability of GT, or more correctly, DTG (i) has the potential to inhibit the growth of other species, especially bacteria and (ii) reveal critical zinc-dependent metalloenzymes or pathways essential for microbial growth. While we are <italic toggle="yes">not</italic> proposing GT/DTG directly as a potential antimicrobial agent for clinical use, the deployment of GT/DTG as a Pathfinder to highlight essential zinc-dependent functionalities in bacterial spp. merits urgent attention, particularly in the ESKAPE group of organisms and the continued emergence of antibiotic resistance.</p></sec></sec><sec id="sec1-3"><title>Antimicrobial effect of GT on Gram positive and negative bacteria</title><p>The antibiotic effects of GT are well documented against <italic toggle="yes">S. aureus</italic> [<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B51" ref-type="bibr">51</xref>,<xref rid="B67" ref-type="bibr">67</xref>]. The MIC of GT has been determined to range between 0.23 and 4 &#x000b5;g/ml for <italic toggle="yes">S. aureus</italic>, including ATCC29213 and unknown strains of <italic toggle="yes">S. aureus</italic> [<xref rid="B49" ref-type="bibr">49</xref>,<xref rid="B68" ref-type="bibr">68&#x02013;70</xref>] (<xref rid="T1" ref-type="table">Table 1</xref>). GT was also found to be an effective growth inhibitor of MRSA strains with an MIC range of 0.32&#x02013;2 &#x000b5;g/ml, and multi-drug resistant <italic toggle="yes">S. aureus</italic> (MDRSA) with an MIC 1 &#x000b5;g/ml [<xref rid="B49" ref-type="bibr">49</xref>,<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B68" ref-type="bibr">68</xref>,<xref rid="B69" ref-type="bibr">69</xref>,<xref rid="B71" ref-type="bibr">71</xref>] (<xref rid="T1" ref-type="table">Table 1</xref>). In both broth dilution and agar-plate assays, GT inhibited MRSA ATCC700699 (MIC: 2 &#x000b5;g/ml) [<xref rid="B49" ref-type="bibr">49</xref>], a strain that is also classified as vancomycin intermediate-resistant (VISA). While most <italic toggle="yes">Staphylococcus</italic> spp. work has focussed on <italic toggle="yes">S. aureus</italic>, GT (2.5 &#x000b5;g/ml) has been shown to inhibit the growth of <italic toggle="yes">Staphylococcus epidermidis</italic> on agar [<xref rid="B70" ref-type="bibr">70</xref>]. <italic toggle="yes">Streptococcus</italic> spp. have been shown to be susceptible to low levels of GT. The GT MIC for <italic toggle="yes">Streptococcus</italic> piscine pathogens was observed to range from 0.08 to 0.64 &#x000b5;g/ml, using the McFarland method [<xref rid="B71" ref-type="bibr">71</xref>] (<xref rid="T1" ref-type="table">Table 1</xref>). This accords with earlier work by Johnson et al. who found that GT (1 &#x000b5;g/ml) had a bacteriostatic effect on a member of the viridans group streptococci [<xref rid="B70" ref-type="bibr">70</xref>]. Studies reporting the effect of GT on clinically relevant <italic toggle="yes">Streptococcus spp</italic>. is limited and deserves further investigation. <italic toggle="yes">Lactococcus garvieae</italic> FP5245 exhibited a GT MIC of 0.32 &#x000b5;g/ml, as did MDR <italic toggle="yes">Enterococcus faecium</italic> 5207 [<xref rid="B71" ref-type="bibr">71</xref>]. Vancomycin-resistant <italic toggle="yes">Enterococcus faecalis</italic> V4932 was shown to be susceptible to culture filtrates containing GT, even when the filtrates were quite dilute (1:512) [<xref rid="B50" ref-type="bibr">50</xref>]. <italic toggle="yes">Bacillus subtilis</italic> growth is also inhibited by GT although the MIC has not yet been established [<xref rid="B67" ref-type="bibr">67</xref>]. GT (3.0 &#x000b5;g/ml) has been shown to have a bacteriostatic effect on <italic toggle="yes">B. subtilis</italic>, leading to increased lag phase of the species to 300 min &#x000b1; 20 [<xref rid="B72" ref-type="bibr">72</xref>]. <italic toggle="yes">M. tuberculosis</italic> H37Rv was found to be particularly sensitive to GT with an IC90 of 0.05 &#x000b5;g/ml [<xref rid="B73" ref-type="bibr">73</xref>]. This sensitivity to GT has been reflected in several other strains of <italic toggle="yes">M. tuberculosis</italic>, with MIC values ranging from 0.006 to 0.06 &#x000b5;g/ml [<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B74" ref-type="bibr">74</xref>]. GT (0.25 &#x000b5;g/ml for 48 h) also significantly inhibited biofilm formation of <italic toggle="yes">S. aureus</italic> (<italic toggle="yes">P</italic>=0.024) [<xref rid="B51" ref-type="bibr">51</xref>]. Strangely, in this study there was a larger percentage biofilm remaining after 48 h when 0.33 &#x000b5;g/ml GT was used when compared to 0.25 &#x000b5;g/ml GT, which had the highest inhibitory effect of the concentrations tested.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><title>The effect of GT on various bacterial species</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Bacterial species/strain</th><th align="left" rowspan="1" colspan="1">GT MIC (&#x000b5;g/ml)</th><th align="left" rowspan="1" colspan="1">Comments</th></tr></thead><tbody><tr><td colspan="3" rowspan="1">
<bold>
<italic toggle="yes">Gram (+)</italic>
</bold>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;ATCC29213 [<xref rid="B68" ref-type="bibr">68</xref>]</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;ATCC29213 [<xref rid="B49" ref-type="bibr">49</xref>]</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;ATCC29213 [<xref rid="B50" ref-type="bibr">50</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">GT-containing extracts</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Unknown strain [<xref rid="B69" ref-type="bibr">69</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Unknown strain [<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Unknown strain [<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">0.23</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Unknown strain [<xref rid="B51" ref-type="bibr">51</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Biofilm: Inhibition at 0.25 &#x000b5;g/ml</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Unknown strain [<xref rid="B67" ref-type="bibr">67</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Zone of inhibition (27 mm) observed on agar</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Antibiotic resistant S. aureus</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;MRSA 2.08 [<xref rid="B50" ref-type="bibr">50</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">GT-containing extracts</td></tr><tr><td rowspan="1" colspan="1">&#x02003;MRSA R3708 [<xref rid="B68" ref-type="bibr">68</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;MRSA ATCC700699 (VISA) [<xref rid="B49" ref-type="bibr">49</xref>]</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;MRSA 3089 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">0.32</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;MRSA [<xref rid="B69" ref-type="bibr">69</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;MDRSA [<xref rid="B69" ref-type="bibr">69</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Staphylococcus epidermidis</italic> [<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Streptococcus iniae FP5228</italic> [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">0.64</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">S. iniae</italic> FP3187 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">0.16</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Streptococcus parauberis</italic> FP3287 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">S. parauberis</italic> SPOF3K [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">0.16</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">S. parauberis</italic> KSP28 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">0.16</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Viridans group streptococcus</italic> [<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Lactococcus garvieae</italic> FP5245 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">0.32</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">MDR Enterococcus faecium</italic> 5207 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">0.32</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">VRE Enterococcus faecalis V4932</italic> [<xref rid="B50" ref-type="bibr">50</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">GT-containing extracts</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Bacillus subtilis</italic> [<xref rid="B67" ref-type="bibr">67</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Zone of inhibition (23 mm) observed on agar</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">B. subtilis</italic> [<xref rid="B72" ref-type="bibr">72</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Increased lag phase on GT (3 &#x000b5;g/ml)</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Mycobacterium tuberculosis</italic> [<xref rid="B73" ref-type="bibr">73</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">IC<sub>90</sub>: 0.05 &#x000b5;g/ml</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">M. tuberculosis</italic> [<xref rid="B74" ref-type="bibr">74</xref>]</td><td rowspan="1" colspan="1">&#x0003c; 0.03</td><td rowspan="1" colspan="1">MIC50: &#x0003c; 0.03 &#x000b5;g/ml</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">M. tuberculosis</italic> (several strains) [<xref rid="B19" ref-type="bibr">19</xref>]</td><td rowspan="1" colspan="1">0.006-0.06</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Gram (-)</italic>
</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Escherichia coli</italic> [<xref rid="B50" ref-type="bibr">50</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">GT-containing extracts</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> [<xref rid="B67" ref-type="bibr">67</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Zone of inhibition (31 mm) observed on agar</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> [<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> ESBL [<xref rid="B50" ref-type="bibr">50</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">GT-containing extracts</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">MDR E. coli</italic> 1137 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">S. typhimurium</italic> (LT2) [<xref rid="B64" ref-type="bibr">64</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">GT (3 &#x000b5;g/ml) inhibited growth of 1.5 &#x000d7; 10<sup>4</sup> cells per 5 ml</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">S. typhimurium</italic> 1181 deep rough mutant [<xref rid="B64" ref-type="bibr">64</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">GT (1.5 &#x000b5;g/ml) inhibited growth of 2.0 &#x000d7; 10<sup>6</sup> cells per 5 ml</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Salmonella schottmuelleri</italic> [<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">&#x0003e;10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">MDR Salmonella typhimurium</italic> 8173 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Salmonella Paratyphi</italic> [<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Pseudomonas aeruginosa</italic> [<xref rid="B51" ref-type="bibr">51</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Biofilm inhibition at 0.13 &#x000b5;g/ml</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Pseudomonas fluorescens</italic> [<xref rid="B67" ref-type="bibr">67</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Zone of inhibition (26 mm) observed on agar</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Klebsiella pneumoniae</italic> [<xref rid="B50" ref-type="bibr">50</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">GT-containing extracts</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Bordetella pertussis</italic> [<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Moraxella catarrhalis</italic> [<xref rid="B70" ref-type="bibr">70</xref>]</td><td rowspan="1" colspan="1">0.2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Proteus sp</italic>. (MTCC No. 426) [<xref rid="B67" ref-type="bibr">67</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Zone of inhibition (29 mm) observed on agar</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Vibrio ichthyoenteri</italic> 0917-1 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">V. ichthyoenteri</italic> FP8487 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">MDR Vibrio parahaemolyticus</italic> 7001 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">&#x0003e;40</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">MDR Enterobacter cloacae</italic> P990252 [<xref rid="B71" ref-type="bibr">71</xref>]</td><td rowspan="1" colspan="1">&#x0003e;40</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Acinetobacter baumannii</italic> [<xref rid="B51" ref-type="bibr">51</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Biofilm inhibition at 0.13 &#x000b5;g/ml</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Burkholderia multivorans</italic> [<xref rid="B51" ref-type="bibr">51</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Biofilm inhibition at 0.13 &#x000b5;g/ml</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Haemophilus influenzae</italic> [<xref rid="B51" ref-type="bibr">51</xref>]</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">Biofilm inhibition at 0.065 &#x000b5;g/ml</td></tr></tbody></table></table-wrap><p>For many Gram negative species, higher dosages were required to effect growth inhibition compared to Gram positive bacteria [<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B51" ref-type="bibr">51</xref>,<xref rid="B67" ref-type="bibr">67</xref>,<xref rid="B70" ref-type="bibr">70</xref>,<xref rid="B71" ref-type="bibr">71</xref>] (<xref rid="T1" ref-type="table">Table 1</xref>). <italic toggle="yes">E. coli</italic>, including MDR strains, exhibit some sensitivity to GT (MIC: 10 &#x000b5;g/ml) [<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B67" ref-type="bibr">67</xref>,<xref rid="B70" ref-type="bibr">70</xref>,<xref rid="B71" ref-type="bibr">71</xref>]. <italic toggle="yes">Salmonella</italic> spp. including MDR <italic toggle="yes">Salmonella typhimurium</italic> 8173 are also sensitive to GT (MIC: 5&#x02013;10 &#x000b5;g/ml) [<xref rid="B64" ref-type="bibr">64</xref>,<xref rid="B70" ref-type="bibr">70</xref>,<xref rid="B71" ref-type="bibr">71</xref>]. In contrast, MDR <italic toggle="yes">Enterobacter cloacae</italic> P990252 and MDR <italic toggle="yes">Vibrio parahaemolyticus</italic> 7001 are considered resistant to GT (MIC: &#x0003e;40 &#x000b5;g/ml) [<xref rid="B71" ref-type="bibr">71</xref>]. Thus, while GT does possess broad-spectrum activity against Gram negative spp., it is less effective than against Gram positive strains, with higher concentrations required to achieve the same growth inhibitory effect.</p><p>GT has also been shown to inhibit biofilm formation in mixed pathogen/<italic toggle="yes">A. fumigatus</italic> cultures where it was active against <italic toggle="yes">A. baumannii</italic>, <italic toggle="yes">Burkholderia multivorans</italic>, <italic toggle="yes">Haemophilus influenzae</italic>, and <italic toggle="yes">P. aeruginosa</italic> where the highest reduction in biofilm formation occurred at GT 0.25, 0.33, 0.06, and 0.2 &#x000b5;g/ml, respectively [<xref rid="B51" ref-type="bibr">51</xref>] (<xref rid="T1" ref-type="table">Table 1</xref>). In co-cultures, it was noted that <italic toggle="yes">A. fumigatus</italic> inhibited <italic toggle="yes">P. aeruginosa</italic> growth due to the production of GT, which was increased in the presence of <italic toggle="yes">P. aeruginosa</italic> [<xref rid="B75" ref-type="bibr">75</xref>]. This inhibition could be rescued by the production of phenazines, redox-active compounds which are toxic to the competing organism [<xref rid="B76" ref-type="bibr">76</xref>], by <italic toggle="yes">P. aeruginosa</italic>. If the phenazine-producing <italic toggle="yes">P. aeruginosa</italic> strain did not produce the phenazine, pyocyanin, which is responsible for upregulation of genes that function in transport and possibly in redox control, as well as down-regulating genes involved in ferric iron acquisition [<xref rid="B77" ref-type="bibr">77</xref>], conidia production in <italic toggle="yes">A. fumigatus</italic> was reduced. In species which do produce the phenazine pyocyanin the opposite occurs, causing enhanced conidia production. Jones and Hancock studied a deep rough mutant of <italic toggle="yes">Salmonella typhimurium</italic>, characterised by a reduction in outer membrane polysaccharide content, and wild-type <italic toggle="yes">S. typhimurium</italic> (LT2) growth in the presence of GT at 24 h [<xref rid="B64" ref-type="bibr">64</xref>]. The deep rough mutant was found to be more sensitive to GT than the wild-type <italic toggle="yes">S. typhimurium</italic>, indicating the outer membrane provides a protective role against GT [<xref rid="B64" ref-type="bibr">64</xref>].</p><p>Of further relevance is that it has been independently shown that GT acts synergistically with vancomycin, fusidic acid and linezolid, to inhibit <italic toggle="yes">S. aureus</italic> growth [<xref rid="B49" ref-type="bibr">49</xref>], an observation which suggests differential mechanistic actions and strongly underpins our rationale for further investigating the GT/DTG couple. These authors did not suggest a metal-dependent basis of GT-mediated inhibition. However, although GT/DTG augments the vancomycin-mediated inhibition of bacterial growth, the impact of zinc addition, or known zinc chelators, after observed combinatorial inhibition is unknown. If the zinc chelator N,N,N&#x02032;,N&#x02032;-<italic toggle="yes">tetrakis</italic>-(2-pyridylmethyl)ethylenediamine (TPEN) does not synergise with vancomycin to cause increased growth inhibition, this would further underpin the uniqueness of GT/DTG and add urgency to establishing its inhibitory action against bacteria.</p></sec><sec id="sec1-4"><title>GT as a probe to investigate the integratory role of zinc in bacteria</title><p>Not only is zinc a component of up to 6% of all proteins in prokaryotes [<xref rid="B78" ref-type="bibr">78</xref>], but several ribosomal proteins contain zinc-binding domains [<xref rid="B79" ref-type="bibr">79</xref>]. In seminal work, zinc has been proposed to be an integrator of metabolism whereby zinc-dependent enzymes, especially those involved in folic acid biosynthesis, sense free zinc availability and somehow control zinc chaperone activity, in addition to adjusting the zinc content of ribosomes [<xref rid="B80" ref-type="bibr">80</xref>]. Moreover, based on its recently observed zinc-chelating ability [<xref rid="B59" ref-type="bibr">59</xref>], Danchin astutely proposed that GT could be used to investigate the biological functions of zinc in cells. We contend that this completely independent verification and validation of our evidence-based hypothesis that the zinc-chelating properties of GT, or more precisely, DTG [<xref rid="B22" ref-type="bibr">22</xref>], have the potential to reveal new insights into the central role of zinc in biological systems, especially bacterial systems, merits serious investigation. Indeed, the significant perturbation of eukaryotic methyl (one-carbon)/methionine cycle due to dysregulated thiomethylation via GT thiomethyltransferase GtmA activity in <italic toggle="yes">A. fumigatus</italic> [<xref rid="B41" ref-type="bibr">41</xref>,<xref rid="B81" ref-type="bibr">81</xref>], especially following deletion of GT oxidoreductase GliT, is functionally equivalent to Danchin&#x02019;s hypothesis which highlights the overlapping importance of zinc in one-carbon metabolism, SAM synthesis and translation [<xref rid="B80" ref-type="bibr">80</xref>,<xref rid="B82" ref-type="bibr">82</xref>]. Furthermore, the reversal of severe GT-mediated growth inhibition in the double-mutant <italic toggle="yes">A. fumigatus</italic> &#x00394;<italic toggle="yes">gliT</italic>&#x00394;<italic toggle="yes">gtmA</italic> by zinc addition [<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B42" ref-type="bibr">42</xref>], further underpins this nascent gliotoxin-zinc nexus as a strategy for investigating the importance of zinc homeostasis, and the essential role of zinc, in prokaryotes naturally lacking the DTG-dissipating enzymes, GliT and GtmA.</p><p>To exploit GT as a Pathfinder the following strategies could be explored: (1) Investigate if GT has global or targeted effects on zinc-metalloenzymes in bacteria; (2) Establish the relative importance of GT ability to chelate free, or eject protein-bound, Zn<sup>2+</sup>; (3) Elucidate the relative contribution of GT as a chelator or ionophore; and (4) Explore, in detail, the synergistic antimicrobial activity of GT with known or emerging antimicrobials (<xref rid="F2" ref-type="fig">Figure 2</xref>). Resultant identification of important GT-sensitive enzymes as virulence contributors could then be validated by deletion studies, and then disrupted by target-specific inhibitors, as antimicrobials, to circumvent the eukaryotic cytotoxicity of GT.</p></sec></sec><sec id="sec2"><title>Concluding remarks</title><p>The GT/DTG couple has significant potential to identify cryptic bacterial intracellular systems as potential drug targets and to sensitise bacteria against pre-existing antibiotics (<xref rid="F1 F2 F3" ref-type="fig">Figures 1-3</xref>). Immediate work is required to mechanistically investigate how this couple can inhibit bacterial growth and exploit this potential to overcome AMR.</p></sec><sec sec-type="summary" id="sec3"><title>Summary</title><list list-type="bullet"><list-item><p>Antimicrobial resistance is a major global problem and new antimicrobials are urgently required.</p></list-item><list-item><p>Thiol-containing compounds and ionophores have potential to provide new directions to overcome antimicrobial resistance.</p></list-item><list-item><p>The reduced form of disulphide-containing, fungal metabolite, gliotoxin (GT) (dithiol gliotoxin [DTG]) is a zinc chelator, and zinc homeostasis has been shown to be essential for bacterial virulence.</p></list-item><list-item><p>GT/DTG can inhibit bacterial growth and augment antibiotic activity by unknown mechanisms.</p></list-item><list-item><p>Zinc may be an integrator of metabolism in bacteria, therefore interference with zinc homeostasis, via GT/DTG, has potential to identify new drug targets.</p></list-item></list></sec></body><back><sec sec-type="COI-statement" id="sec4"><title>Competing Interests</title><p>The authors declare that there are no competing interests associated with the manuscript.</p></sec><sec sec-type="funding" id="sec5"><title>Funding</title><p>This work was part-funded by Leeds-Beckett University and Maynooth University PhD studentship (to S.G.D.).</p></sec><sec sec-type="author-contrib" id="sec6"><title>Author Contribution</title><p>R.A.O. and S.D. conceived the work. R.A.O. co-ordinated and managed the writing process. S.G.D., S.D., G.W.J., and R.A.O. have written initial sections of the manuscript. All authors have contributed to the editing and finalization of the manuscript. All authors have read and approved the final version of the manuscript.</p></sec><glossary><title>Abbreviations</title><def-list list-content="abbreviations"><def-item><term id="G1">1C</term><def><p>one carbon</p></def></def-item><def-item><term id="G2">AMR</term><def><p>antimicrobial resistance</p></def></def-item><def-item><term id="G3">BmGT</term><def><p>bisdethiobis(methylthio)gliotoxin</p></def></def-item><def-item><term id="G4">CTX</term><def><p>cefotaxime</p></def></def-item><def-item><term id="G5">DTG</term><def><p>dithiol gliotoxin</p></def></def-item><def-item><term id="G6">DTP</term><def><p>dithiolopyrrolone</p></def></def-item><def-item><term id="G7">ETP</term><def><p>epipolythiodioxopiperazine</p></def></def-item><def-item><term id="G8">FDA</term><def><p>Food and Drug Administration</p></def></def-item><def-item><term id="G9">GSH</term><def><p>glutathione</p></def></def-item><def-item><term id="G10">GT</term><def><p>gliotoxin</p></def></def-item><def-item><term id="G11">L-Cys</term><def><p>L-cysteine</p></def></def-item><def-item><term id="G12">MDR</term><def><p>multi-drug resistant</p></def></def-item><def-item><term id="G13">MDRSA</term><def><p>multidrug-resistant <italic toggle="yes">Staphylococcus aureus</italic></p></def></def-item><def-item><term id="G14">MIC</term><def><p>minimum inhibitory concentration</p></def></def-item><def-item><term id="G15">MRSA</term><def><p>methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic></p></def></def-item><def-item><term id="G16">MSH</term><def><p>mycothiol</p></def></def-item><def-item><term id="G17">ROS</term><def><p>reactive oxygen species</p></def></def-item><def-item><term id="G18">SAH</term><def><p><italic toggle="yes">S</italic>-adenosyl homocysteine</p></def></def-item><def-item><term id="G19">SAM</term><def><p>S-adenosyl methionine</p></def></def-item><def-item><term id="G20">TCEP</term><def><p>Tris(2-carboxyethyl)phosphine</p></def></def-item><def-item><term id="G21">TPEN</term><def><p>N,N,N&#x02032;,N&#x02032;-<italic toggle="yes">tetrakis</italic>-(2-pyridylmethyl)ethylenediamine</p></def></def-item><def-item><term id="G22">VISA</term><def><p>vancomycin intermediate <italic toggle="yes">Staphylococcus aureus</italic></p></def></def-item><def-item><term id="G23">VRE</term><def><p>vancomycin-resistant enterococci</p></def></def-item></def-list></glossary><ref-list id="ref1"><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="book"><person-group><collab>World Health Organization</collab></person-group>. (<year>2014</year>) <source>Antimicrobial Resistance: Global report on surveillance</source>, <publisher-name>WHO</publisher-name>, <publisher-loc>Geneva, Switzerland</publisher-loc></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>O'Neill</surname>
<given-names>J.</given-names></string-name></person-group> (<year>2014</year>) <source>Review on antimicrobial resistance, &#x0201c;Antimicrobial resistance: tackling a crisis for the health and wealth of nations&#x0201d;</source>, <publisher-name>HM Government</publisher-name>, <publisher-loc>London, UK</publisher-loc></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tran</surname>
<given-names>T.T.</given-names></string-name>, <string-name><surname>Miller</surname>
<given-names>W.R.</given-names></string-name>, <string-name><surname>Shamoo</surname>
<given-names>Y.</given-names></string-name> and <string-name><surname>Arias</surname>
<given-names>C.A.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Targeting cell membrane adaptation as a novel antimicrobial strategy</article-title>. <source>Curr. Opin. Microbiol.</source>
<volume>33</volume>, <fpage>91</fpage>&#x02013;<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/j.mib.2016.07.002</pub-id><?supplied-pmid 27458841?><pub-id pub-id-type="pmid">27458841</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Taubes</surname>
<given-names>G.</given-names></string-name></person-group> (<year>2008</year>) <article-title>The bacteria fight back</article-title>. <source>In Science</source>
<publisher-loc>United States</publisher-loc>, <fpage>356</fpage>&#x02013;<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1126/science.321.5887.356</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klevens</surname>
<given-names>R.M.</given-names></string-name>, <string-name><surname>Morrison</surname>
<given-names>M.A.</given-names></string-name>, <string-name><surname>Nadle</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Petit</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Gershman</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Ray</surname>
<given-names>S.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2007</year>) <article-title>Invasive methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> infections in the United States</article-title>. <source>JAMA</source>
<volume>298</volume>, <fpage>1763</fpage>&#x02013;<lpage>1771</lpage>
<pub-id pub-id-type="doi">10.1001/jama.298.15.1763</pub-id><?supplied-pmid 17940231?><pub-id pub-id-type="pmid">17940231</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahmed</surname>
<given-names>M.O.</given-names></string-name> and <string-name><surname>Baptiste</surname>
<given-names>K.E.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health</article-title>. <source>Microb. Drug Resist.</source>
<volume>24</volume>, <fpage>590</fpage>&#x02013;<lpage>606</lpage>
<pub-id pub-id-type="doi">10.1089/mdr.2017.0147</pub-id><?supplied-pmid 29058560?><pub-id pub-id-type="pmid">29058560</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Santajit</surname>
<given-names>S.</given-names></string-name> and <string-name><surname>Indrawattana</surname>
<given-names>N.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Mechanisms of antimicrobial resistance in ESKAPE pathogens</article-title>. <source>Biomed. Res. Int.</source>
<volume>2016</volume>, <fpage>2475067</fpage>
<pub-id pub-id-type="doi">10.1155/2016/2475067</pub-id><?supplied-pmid 27274985?><pub-id pub-id-type="pmid">27274985</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group><collab>GBD 2019 Antimicrobial Resistance Collaborators</collab></person-group> (<year>2022</year>) <article-title>Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet</source>
<volume>400</volume>, <fpage>2221</fpage>&#x02013;<lpage>2248</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(22)02185-7</pub-id><?supplied-pmid 36423648?><pub-id pub-id-type="pmid">36423648</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harbut</surname>
<given-names>M.B.</given-names></string-name>, <string-name><surname>Vilcheze</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Hensler</surname>
<given-names>M.E.</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>B.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2015</year>) <article-title>Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>112</volume>, <fpage>4453</fpage>&#x02013;<lpage>4458</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1504022112</pub-id><?supplied-pmid 25831516?><pub-id pub-id-type="pmid">25831516</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liras</surname>
<given-names>P.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Holomycin, a dithiolopyrrolone compound produced by <italic toggle="yes">Streptomyces clavuligerus</italic></article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>98</volume>, <fpage>1023</fpage>&#x02013;<lpage>1030</lpage>
<pub-id pub-id-type="doi">10.1007/s00253-013-5410-z</pub-id><?supplied-pmid 24323287?><pub-id pub-id-type="pmid">24323287</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chan</surname>
<given-names>A.N.</given-names></string-name>, <string-name><surname>Shiver</surname>
<given-names>A.L.</given-names></string-name>, <string-name><surname>Wever</surname>
<given-names>W.J.</given-names></string-name>, <string-name><surname>Razvi</surname>
<given-names>S.Z.</given-names></string-name>, <string-name><surname>Traxler</surname>
<given-names>M.F.</given-names></string-name> and <string-name><surname>Li</surname>
<given-names>B.</given-names></string-name></person-group> (<year>2017</year>) <article-title>Role for dithiolopyrrolones in disrupting bacterial metal homeostasis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>114</volume>, <fpage>2717</fpage>&#x02013;<lpage>2722</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1612810114</pub-id><?supplied-pmid 28209778?><pub-id pub-id-type="pmid">28209778</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bohlmann</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>De Oliveira</surname>
<given-names>D.M.P.</given-names></string-name>, <string-name><surname>El-Deeb</surname>
<given-names>I.M.</given-names></string-name>, <string-name><surname>Brazel</surname>
<given-names>E.B.</given-names></string-name>, <string-name><surname>Harbison-Price</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Ong</surname>
<given-names>C.Y.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2018</year>) <article-title>Chemical synergy between ionophore PBT2 and Zinc reverses antibiotic resistance</article-title>. <source>mBio</source>
<volume>9</volume>, <pub-id pub-id-type="doi">10.1128/mBio.02391-18</pub-id><?supplied-pmid 30538186?><pub-id pub-id-type="pmid">30538186</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harbison-Price</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Ferguson</surname>
<given-names>S.A.</given-names></string-name>, <string-name><surname>Heikal</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Taiaroa</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Hards</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Nakatani</surname>
<given-names>Y.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2020</year>) <article-title>Multiple bactericidal mechanisms of the zinc ionophore PBT2</article-title>. <source>mSphere</source>
<volume>5</volume>, <fpage>e00157</fpage>&#x02013;<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1128/mSphere.00157-20</pub-id><?supplied-pmid 32188750?><pub-id pub-id-type="pmid">32188750</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van Zuylen</surname>
<given-names>E.M.</given-names></string-name>, <string-name><surname>Ferguson</surname>
<given-names>S.A.</given-names></string-name>, <string-name><surname>Hughes</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Rennison</surname>
<given-names>D.</given-names></string-name>, <string-name><surname>Brimble</surname>
<given-names>M.A.</given-names></string-name> and <string-name><surname>Cook</surname>
<given-names>G.M.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Disruption of metallostasis in the anaerobic human pathogen fusobacterium nucleatum by the zinc ionophore PBT2</article-title>. <source>ACS Infect Dis.</source>
<volume>7</volume>, <fpage>2285</fpage>&#x02013;<lpage>2298</lpage>
<pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00887</pub-id><?supplied-pmid 34259502?><pub-id pub-id-type="pmid">34259502</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Oliveira</surname>
<given-names>D.M.P.</given-names></string-name>, <string-name><surname>Forde</surname>
<given-names>B.M.</given-names></string-name>, <string-name><surname>Phan</surname>
<given-names>M.D.</given-names></string-name>, <string-name><surname>Steiner</surname>
<given-names>B.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>B.</given-names></string-name>, <string-name><surname>Zuegg</surname>
<given-names>J.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2022</year>) <article-title>Rescuing tetracycline class antibiotics for the treatment of multidrug-resistant acinetobacter baumannii pulmonary infection</article-title>. <source>mBio</source>
<volume>13</volume>, <fpage>e0351721</fpage>
<pub-id pub-id-type="doi">10.1128/mbio.03517-21</pub-id><?supplied-pmid 35012353?><pub-id pub-id-type="pmid">35012353</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dolan</surname>
<given-names>S.K.</given-names></string-name>, <string-name><surname>O'Keeffe</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name> and <string-name><surname>Doyle</surname>
<given-names>S.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Resistance is not futile: Gliotoxin biosynthesis, functionality and utility</article-title>. <source>Trends Microbiol.</source>
<volume>23</volume>, <fpage>419</fpage>&#x02013;<lpage>428</lpage>
<pub-id pub-id-type="doi">10.1016/j.tim.2015.02.005</pub-id><?supplied-pmid 25766143?><pub-id pub-id-type="pmid">25766143</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carberry</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Molloy</surname>
<given-names>E.</given-names></string-name>, <string-name><surname>Hammel</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>O'Keeffe</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name>, <string-name><surname>Kavanagh</surname>
<given-names>K.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2012</year>) <article-title>Gliotoxin effects on fungal growth: mechanisms and exploitation</article-title>. <source>Fungal Genet. Biol.</source>
<volume>49</volume>, <fpage>302</fpage>&#x02013;<lpage>312</lpage>
<pub-id pub-id-type="doi">10.1016/j.fgb.2012.02.003</pub-id><?supplied-pmid 22405895?><pub-id pub-id-type="pmid">22405895</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nieminen</surname>
<given-names>S.M.</given-names></string-name>, <string-name><surname>M&#x000e4;ki-Paakkanen</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Hirvonen</surname>
<given-names>M.R.</given-names></string-name>, <string-name><surname>Roponen</surname>
<given-names>M.</given-names></string-name> and <string-name><surname>von Wright</surname>
<given-names>A.</given-names></string-name></person-group> (<year>2002</year>) <article-title>Genotoxicity of gliotoxin, a secondary metabolite of <italic toggle="yes">Aspergillus fumigatus</italic>, in a battery of short-term test systems</article-title>. <source>Mutat. Res.</source>
<volume>520</volume>, <fpage>161</fpage>&#x02013;<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1016/S1383-5718(02)00202-4</pub-id><?supplied-pmid 12297156?><pub-id pub-id-type="pmid">12297156</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tompsett</surname>
<given-names>R.</given-names></string-name>, <string-name><surname>Mc</surname>
<given-names>D.W.</given-names></string-name> and <string-name><surname>Kidd</surname>
<given-names>J.G.</given-names></string-name></person-group> (<year>1950</year>) <article-title>Tuberculostatic activity of blood and urine from animals given gliotoxin</article-title>. <source>J. Immunol.</source>
<volume>65</volume>, <fpage>59</fpage>&#x02013;<lpage>63</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.65.1.59</pub-id><?supplied-pmid 15436984?><pub-id pub-id-type="pmid">15436984</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Coleman</surname>
<given-names>J.J.</given-names></string-name>, <string-name><surname>Ghosh</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Okoli</surname>
<given-names>I.</given-names></string-name> and <string-name><surname>Mylonakis</surname>
<given-names>E.</given-names></string-name></person-group> (<year>2011</year>) <article-title>Antifungal activity of microbial secondary metabolites</article-title>. <source>PloS ONE</source>
<volume>6</volume>, <fpage>e25321</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025321</pub-id><?supplied-pmid 21966496?><pub-id pub-id-type="pmid">21966496</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Traynor</surname>
<given-names>A.M.</given-names></string-name>, <string-name><surname>Owens</surname>
<given-names>R.A.</given-names></string-name>, <string-name><surname>Coughlin</surname>
<given-names>C.M.</given-names></string-name>, <string-name><surname>Holton</surname>
<given-names>M.C.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name>, <string-name><surname>Calera</surname>
<given-names>J.A.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2021</year>) <article-title>At the metal-metabolite interface in <italic toggle="yes">Aspergillus fumigatus</italic>: towards untangling the intersecting roles of zinc and gliotoxin</article-title>. <source>Microbiology (Reading)</source>
<volume>167</volume>, <fpage>001106</fpage>
<pub-id pub-id-type="doi">10.1099/mic.0.001106</pub-id><?supplied-pmid 34738889?><pub-id pub-id-type="pmid">34738889</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saleh</surname>
<given-names>A.A.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name>, <string-name><surname>Tinley</surname>
<given-names>F.C.</given-names></string-name>, <string-name><surname>Delaney</surname>
<given-names>S.F.</given-names></string-name>, <string-name><surname>Alabbadi</surname>
<given-names>S.H.</given-names></string-name>, <string-name><surname>Fenlon</surname>
<given-names>K.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2018</year>) <article-title>Systems impact of zinc chelation by the epipolythiodioxopiperazine dithiol gliotoxin in <italic toggle="yes">Aspergillus fumigatus</italic>: a new direction in natural product functionality</article-title>. <source>Metallomics</source>
<volume>10</volume>, <fpage>854</fpage>&#x02013;<lpage>866</lpage>
<pub-id pub-id-type="doi">10.1039/C8MT00052B</pub-id><?supplied-pmid 29897360?><pub-id pub-id-type="pmid">29897360</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huber</surname>
<given-names>E.M.</given-names></string-name></person-group> (<year>2022</year>) <article-title>Epipolythiodioxopiperazine-based natural products: building blocks, biosynthesis and biological activities</article-title>. <source>ChemBioChem</source>
<volume>23</volume>, <fpage>e202200341</fpage>
<pub-id pub-id-type="doi">10.1002/cbic.202200341</pub-id><?supplied-pmid 35997236?><pub-id pub-id-type="pmid">35997236</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vicentefranqueira</surname>
<given-names>R.</given-names></string-name>, <string-name><surname>Amich</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Marin</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Sanchez</surname>
<given-names>C.I.</given-names></string-name>, <string-name><surname>Leal</surname>
<given-names>F.</given-names></string-name> and <string-name><surname>Calera</surname>
<given-names>J.A.</given-names></string-name></person-group> (<year>2018</year>) <article-title>The transcription factor ZafA regulates the homeostatic and adaptive response to zinc starvation in <italic toggle="yes">Aspergillus fumigatu</italic>s</article-title>. <source>Genes (Basel)</source>
<volume>9</volume>, <fpage>318</fpage>
<pub-id pub-id-type="doi">10.3390/genes9070318</pub-id><?supplied-pmid 29949939?><pub-id pub-id-type="pmid">29949939</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cramer</surname>
<given-names>R.A.</given-names></string-name>, <string-name><surname>Gamcsik</surname>
<given-names>M.P.</given-names></string-name>, <string-name><surname>Brooking</surname>
<given-names>R.M.</given-names></string-name>, <string-name><surname>Najvar</surname>
<given-names>L.K.</given-names></string-name>, <string-name><surname>Kirkpatrick</surname>
<given-names>W.R.</given-names></string-name>, <string-name><surname>Patterson</surname>
<given-names>T.F.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2006</year>) <article-title>Disruption of a nonribosomal peptide synthetase in <italic toggle="yes">Aspergillus fumigatus</italic> eliminates gliotoxin production</article-title>. <source>Eukaryot Cell.</source>
<volume>5</volume>, <fpage>972</fpage>&#x02013;<lpage>980</lpage>
<pub-id pub-id-type="doi">10.1128/EC.00049-06</pub-id><?supplied-pmid 16757745?><pub-id pub-id-type="pmid">16757745</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O'Keeffe</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Hammel</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Owens</surname>
<given-names>R.A.</given-names></string-name>, <string-name><surname>Keane</surname>
<given-names>T.M.</given-names></string-name>, <string-name><surname>Fitzpatrick</surname>
<given-names>D.A.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2014</year>) <article-title>RNA-seq reveals the pan-transcriptomic impact of attenuating the gliotoxin self-protection mechanism in Aspergillus fumigatus</article-title>. <source>BMC Genomics</source>
<volume>15</volume>, <fpage>894</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-15-894</pub-id><?supplied-pmid 25311525?><pub-id pub-id-type="pmid">25311525</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moloney</surname>
<given-names>N.M.</given-names></string-name>, <string-name><surname>Owens</surname>
<given-names>R.A.</given-names></string-name>, <string-name><surname>Meleady</surname>
<given-names>P.</given-names></string-name>, <string-name><surname>Henry</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Dolan</surname>
<given-names>S.K.</given-names></string-name>, <string-name><surname>Mulvihill</surname>
<given-names>E.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2016</year>) <article-title>The iron-responsive microsomal proteome of Aspergillus fumigatus</article-title>. <source>J. Proteomics</source>
<volume>136</volume>, <fpage>99</fpage>&#x02013;<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1016/j.jprot.2015.12.025</pub-id><?supplied-pmid 26739764?><pub-id pub-id-type="pmid">26739764</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bok</surname>
<given-names>J.W.</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>D.</given-names></string-name>, <string-name><surname>Balajee</surname>
<given-names>S.A.</given-names></string-name>, <string-name><surname>Marr</surname>
<given-names>K.A.</given-names></string-name>, <string-name><surname>Andes</surname>
<given-names>D.</given-names></string-name>, <string-name><surname>Nielsen</surname>
<given-names>K.F.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2006</year>) <article-title>GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulence</article-title>. <source>Infect. Immun.</source>
<volume>74</volume>, <fpage>6761</fpage>&#x02013;<lpage>6768</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.00780-06</pub-id><?supplied-pmid 17030582?><pub-id pub-id-type="pmid">17030582</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gardiner</surname>
<given-names>D.M.</given-names></string-name>, <string-name><surname>Cozijnsen</surname>
<given-names>A.J.</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>L.M.</given-names></string-name>, <string-name><surname>Pedras</surname>
<given-names>M.S.</given-names></string-name> and <string-name><surname>Howlett</surname>
<given-names>B.J.</given-names></string-name></person-group> (<year>2004</year>) <article-title>The sirodesmin biosynthetic gene cluster of the plant pathogenic fungus Leptosphaeria maculans</article-title>. <source>Mol. Microbiol.</source>
<volume>53</volume>, <fpage>1307</fpage>&#x02013;<lpage>1318</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04215.x</pub-id><?supplied-pmid 15387811?><pub-id pub-id-type="pmid">15387811</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scharf</surname>
<given-names>D.H.</given-names></string-name>, <string-name><surname>Remme</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Heinekamp</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Hortschansky</surname>
<given-names>P.</given-names></string-name>, <string-name><surname>Brakhage</surname>
<given-names>A.A.</given-names></string-name> and <string-name><surname>Hertweck</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2010</year>) <article-title>Transannular disulfide formation in gliotoxin biosynthesis and its role in self-resistance of the human pathogen <italic toggle="yes">Aspergillus fumigatus</italic></article-title>. <source>J. Am. Chem. Soc.</source>
<volume>132</volume>, <fpage>10136</fpage>&#x02013;<lpage>10141</lpage>
<pub-id pub-id-type="doi">10.1021/ja103262m</pub-id><?supplied-pmid 20593880?><pub-id pub-id-type="pmid">20593880</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scharf</surname>
<given-names>D.H.</given-names></string-name>, <string-name><surname>Remme</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Habel</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Chankhamjon</surname>
<given-names>P.</given-names></string-name>, <string-name><surname>Scherlach</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Heinekamp</surname>
<given-names>T.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>A dedicated glutathione S-transferase mediates carbon-sulfur bond formation in gliotoxin biosynthesis</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>133</volume>, <fpage>12322</fpage>&#x02013;<lpage>12325</lpage>
<pub-id pub-id-type="doi">10.1021/ja201311d</pub-id><?supplied-pmid 21749092?><pub-id pub-id-type="pmid">21749092</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Carberry</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Schrettl</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>I.</given-names></string-name>, <string-name><surname>Stephens</surname>
<given-names>J.C.</given-names></string-name>, <string-name><surname>Barry</surname>
<given-names>S.M.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>The role of glutathione S-transferase GliG in gliotoxin biosynthesis in <italic toggle="yes">Aspergillus fumigatus</italic></article-title>. <source>Chem. Biol.</source>
<volume>18</volume>, <fpage>542</fpage>&#x02013;<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1016/j.chembiol.2010.12.022</pub-id><?supplied-pmid 21513890?><pub-id pub-id-type="pmid">21513890</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schrettl</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Carberry</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Kavanagh</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Haas</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name>, <string-name><surname>O'Brien</surname>
<given-names>J.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2010</year>) <article-title>Self-protection against gliotoxin-a component of the gliotoxin biosynthetic cluster, GliT, completely protects <italic toggle="yes">Aspergillus fumigatus</italic> against exogenous gliotoxin</article-title>. <source>PLoS Pathog.</source>
<volume>6</volume>, <fpage>e1000952</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000952</pub-id><?supplied-pmid 20548963?><pub-id pub-id-type="pmid">20548963</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dolan</surname>
<given-names>S.K.</given-names></string-name>, <string-name><surname>Owens</surname>
<given-names>R.A.</given-names></string-name>, <string-name><surname>O'Keeffe</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Hammel</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Fitzpatrick</surname>
<given-names>D.A.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2014</year>) <article-title>Regulation of nonribosomal peptide synthesis: Bis-thiomethylation attenuates gliotoxin biosynthesis in <italic toggle="yes">Aspergillus fumigatus</italic></article-title>. <source>Chem. Biol.</source>
<volume>21</volume>, <fpage>999</fpage>&#x02013;<lpage>1012</lpage>
<pub-id pub-id-type="doi">10.1016/j.chembiol.2014.07.006</pub-id><?supplied-pmid 25126990?><pub-id pub-id-type="pmid">25126990</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scharf</surname>
<given-names>D.H.</given-names></string-name>, <string-name><surname>Habel</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Heinekamp</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Brakhage</surname>
<given-names>A.A.</given-names></string-name> and <string-name><surname>Hertweck</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Opposed effects of enzymatic gliotoxin N- and S-methylations</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>136</volume>, <fpage>11674</fpage>&#x02013;<lpage>11679</lpage>
<pub-id pub-id-type="doi">10.1021/ja5033106</pub-id><?supplied-pmid 25062268?><pub-id pub-id-type="pmid">25062268</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>B.</given-names></string-name>, <string-name><surname>Wever</surname>
<given-names>W.J.</given-names></string-name>, <string-name><surname>Walsh</surname>
<given-names>C.T.</given-names></string-name> and <string-name><surname>Bowers</surname>
<given-names>A.A.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Dithiolopyrrolones: biosynthesis, synthesis, and activity of a unique class of disulfide-containing antibiotics</article-title>. <source>Nat. Prod. Rep.</source>
<volume>31</volume>, <fpage>905</fpage>&#x02013;<lpage>923</lpage>
<pub-id pub-id-type="doi">10.1039/C3NP70106A</pub-id><?supplied-pmid 24835149?><pub-id pub-id-type="pmid">24835149</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>B.</given-names></string-name> and <string-name><surname>Walsh</surname>
<given-names>C.T.</given-names></string-name></person-group> (<year>2011</year>) <article-title><italic toggle="yes">Streptomyces clavuligerus</italic> HlmI is an intramolecular disulfide-forming dithiol oxidase in holomycin biosynthesis</article-title>. <source>Biochemistry</source>
<volume>50</volume>, <fpage>4615</fpage>&#x02013;<lpage>4622</lpage>
<pub-id pub-id-type="doi">10.1021/bi200321c</pub-id><?supplied-pmid 21504228?><pub-id pub-id-type="pmid">21504228</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bernardo</surname>
<given-names>P.H.</given-names></string-name>, <string-name><surname>Brasch</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Chai</surname>
<given-names>C.L.</given-names></string-name> and <string-name><surname>Waring</surname>
<given-names>P.</given-names></string-name></person-group> (<year>2003</year>) <article-title>A novel redox mechanism for the glutathione-dependent reversible uptake of a fungal toxin in cells</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume>, <fpage>46549</fpage>&#x02013;<lpage>46555</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M304825200</pub-id><?supplied-pmid 12947114?><pub-id pub-id-type="pmid">12947114</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>K&#x000f6;nig</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Pace</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Pein</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Heinekamp</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Kramer</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Romp</surname>
<given-names>E.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2019</year>) <article-title>Gliotoxin from <italic toggle="yes">Aspergillus fumigatus</italic> abrogates leukotriene B(4) formation through inhibition of leukotriene A(4) hydrolase</article-title>. <source>Cell Chem. Biol.</source>
<volume>26</volume>, <fpage>524</fpage>&#x02013;<lpage>534</lpage>
<pub-id pub-id-type="doi">10.1016/j.chembiol.2019.01.001</pub-id><?supplied-pmid 30745237?><pub-id pub-id-type="pmid">30745237</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>D.N.</given-names></string-name>, <string-name><surname>Toyotome</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Muraosa</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Wuren</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Bunsupa</surname>
<given-names>S.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2014</year>) <article-title>GliA in <italic toggle="yes">Aspergillus fumigatus</italic> is required for its tolerance to gliotoxin and affects the amount of extracellular and intracellular gliotoxin</article-title>. <source>Med. Mycol.</source>
<volume>52</volume>, <fpage>506</fpage>&#x02013;<lpage>518</lpage>
<pub-id pub-id-type="doi">10.1093/mmy/myu007</pub-id><?supplied-pmid 24847038?><pub-id pub-id-type="pmid">24847038</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Owens</surname>
<given-names>R.A.</given-names></string-name>, <string-name><surname>O'Keeffe</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>E.B.</given-names></string-name>, <string-name><surname>Dolan</surname>
<given-names>S.K.</given-names></string-name>, <string-name><surname>Hammel</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Sheridan</surname>
<given-names>K.J.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2015</year>) <article-title>Interplay between Gliotoxin Resistance, Secretion, and the Methyl/Methionine Cycle in <italic toggle="yes">Aspergillus fumigatus</italic></article-title>. <source>Eukaryot Cell.</source>
<volume>14</volume>, <fpage>941</fpage>&#x02013;<lpage>957</lpage>
<pub-id pub-id-type="doi">10.1128/EC.00055-15</pub-id><?supplied-pmid 26150413?><pub-id pub-id-type="pmid">26150413</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dolan</surname>
<given-names>S.K.</given-names></string-name>, <string-name><surname>Bock</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Hering</surname>
<given-names>V.</given-names></string-name>, <string-name><surname>Owens</surname>
<given-names>R.A.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name>, <string-name><surname>Blankenfeldt</surname>
<given-names>W.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2017</year>) <article-title>Structural, mechanistic and functional insight into gliotoxin bis-thiomethylation in <italic toggle="yes">Aspergillus fumigatus</italic></article-title>. <source>Open Biol.</source>
<volume>7</volume>, <fpage>160292</fpage>
<pub-id pub-id-type="doi">10.1098/rsob.160292</pub-id><?supplied-pmid 28179499?><pub-id pub-id-type="pmid">28179499</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Strauss</surname>
<given-names>J.</given-names></string-name> and <string-name><surname>Reyes-Dominguez</surname>
<given-names>Y.</given-names></string-name></person-group> (<year>2011</year>) <article-title>Regulation of secondary metabolism by chromatin structure and epigenetic codes</article-title>. <source>Fungal Genet. Biol.</source>
<volume>48</volume>, <fpage>62</fpage>&#x02013;<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1016/j.fgb.2010.07.009</pub-id><?supplied-pmid 20659575?><pub-id pub-id-type="pmid">20659575</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burgos</surname>
<given-names>E.S.</given-names></string-name>, <string-name><surname>Gulab</surname>
<given-names>S.A.</given-names></string-name>, <string-name><surname>Cassera</surname>
<given-names>M.B.</given-names></string-name> and <string-name><surname>Schramm</surname>
<given-names>V.L.</given-names></string-name></person-group> (<year>2012</year>) <article-title>Luciferase-based assay for adenosine: application to S-adenosyl-L-homocysteine hydrolase</article-title>. <source>Anal. Chem.</source>
<volume>84</volume>, <fpage>3593</fpage>&#x02013;<lpage>3598</lpage>
<pub-id pub-id-type="doi">10.1021/ac203297z</pub-id><?supplied-pmid 22416759?><pub-id pub-id-type="pmid">22416759</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gallagher</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Owens</surname>
<given-names>R.A.</given-names></string-name>, <string-name><surname>Dolan</surname>
<given-names>S.K.</given-names></string-name>, <string-name><surname>O'Keeffe</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Schrettl</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Kavanagh</surname>
<given-names>K.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2012</year>) <article-title>The <italic toggle="yes">Aspergillus fumigatus</italic> protein gliK protects against oxidative stress and is essential for gliotoxin biosynthesis</article-title>. <source>Eukaryot. Cell.</source>
<volume>11</volume>, <fpage>1226</fpage>&#x02013;<lpage>1238</lpage>
<pub-id pub-id-type="doi">10.1128/EC.00113-12</pub-id><?supplied-pmid 22903976?><pub-id pub-id-type="pmid">22903976</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sheridan</surname>
<given-names>K.J.</given-names></string-name>, <string-name><surname>Lechner</surname>
<given-names>B.E.</given-names></string-name>, <string-name><surname>O'Keeffe</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Keller</surname>
<given-names>M.A.</given-names></string-name>, <string-name><surname>Werner</surname>
<given-names>E.R.</given-names></string-name>, <string-name><surname>Lindner</surname>
<given-names>H.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2016</year>) <article-title>Ergothioneine biosynthesis and functionality in the opportunistic fungal pathogen, <italic toggle="yes">Aspergillus fumigatus</italic></article-title>. <source>Sci. Rep.</source>
<volume>6</volume>, <fpage>35306</fpage>
<pub-id pub-id-type="doi">10.1038/srep35306</pub-id><?supplied-pmid 27748436?><pub-id pub-id-type="pmid">27748436</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Castro</surname>
<given-names>P.A.</given-names></string-name>, <string-name><surname>Colabardini</surname>
<given-names>A.C.</given-names></string-name>, <string-name><surname>Moraes</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Horta</surname>
<given-names>M.A.C.</given-names></string-name>, <string-name><surname>Knowles</surname>
<given-names>S.L.</given-names></string-name>, <string-name><surname>Raja</surname>
<given-names>H.A.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2022</year>) <article-title>Regulation of gliotoxin biosynthesis and protection in <italic toggle="yes">Aspergillus</italic> species</article-title>. <source>PLos Genet.</source>
<volume>18</volume>, <fpage>e1009965</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1009965</pub-id><?supplied-pmid 35041649?><pub-id pub-id-type="pmid">35041649</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Traynor</surname>
<given-names>A.M.</given-names></string-name>, <string-name><surname>Sheridan</surname>
<given-names>K.J.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name>, <string-name><surname>Calera</surname>
<given-names>J.A.</given-names></string-name> and <string-name><surname>Doyle</surname>
<given-names>S.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Involvement of sulfur in the biosynthesis of essential metabolites in pathogenic fungi of animals, particularly <italic toggle="yes">Aspergillus</italic> spp.: molecular and therapeutic implications</article-title>. <source>Front. Microbiol.</source>
<volume>10</volume>, <fpage>2859</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2019.02859</pub-id><?supplied-pmid 31921039?><pub-id pub-id-type="pmid">31921039</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Esteban</surname>
<given-names>P.</given-names></string-name>, <string-name><surname>Redrado</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Comas</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Domingo</surname>
<given-names>M.P.</given-names></string-name>, <string-name><surname>Mill&#x000e1;n-Lou</surname>
<given-names>M.I.</given-names></string-name>, <string-name><surname>Seral</surname>
<given-names>C.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2021</year>) <article-title><italic toggle="yes">In vitro</italic> and <italic toggle="yes">in vivo</italic> antibacterial activity of gliotoxin alone and in combination with antibiotics against <italic toggle="yes">Staphylococcus aureus</italic></article-title>. <source>Toxins (Basel)</source>
<volume>13</volume>, <fpage>85</fpage>
<pub-id pub-id-type="doi">10.3390/toxins13020085</pub-id><?supplied-pmid 33498622?><pub-id pub-id-type="pmid">33498622</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Svahn</surname>
<given-names>K.S.</given-names></string-name>, <string-name><surname>G&#x000f6;ransson</surname>
<given-names>U.</given-names></string-name>, <string-name><surname>El-Seedi</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Bohlin</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Larsson</surname>
<given-names>D.G.</given-names></string-name>, <string-name><surname>Olsen</surname>
<given-names>B.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2012</year>) <article-title>Antimicrobial activity of filamentous fungi isolated from highly antibiotic-contaminated river sediment</article-title>. <source>Infect. Ecol. Epidemiol.</source>
<volume>2</volume>, <fpage>11591</fpage>
<pub-id pub-id-type="doi">10.3402/iee.v2i0.11591</pub-id><?supplied-pmid 22957125?><pub-id pub-id-type="pmid">22957125</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reece</surname>
<given-names>E.</given-names></string-name>, <string-name><surname>Doyle</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Greally</surname>
<given-names>P.</given-names></string-name>, <string-name><surname>Renwick</surname>
<given-names>J.</given-names></string-name> and <string-name><surname>McClean</surname>
<given-names>S.</given-names></string-name></person-group> (<year>2018</year>) <article-title><italic toggle="yes">Aspergillus fumigatus</italic> inhibits <italic toggle="yes">Pseudomonas aeruginosa</italic> in co-culture: implications of a mutually antagonistic relationship on virulence and inflammation in the CF airway</article-title>. <source>Front. Microbiol.</source>
<volume>9</volume>, <fpage>1205</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2018.01205</pub-id><?supplied-pmid 29922270?><pub-id pub-id-type="pmid">29922270</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Svahn</surname>
<given-names>K.S.</given-names></string-name>, <string-name><surname>Goransson</surname>
<given-names>U.</given-names></string-name>, <string-name><surname>Chryssanthou</surname>
<given-names>E.</given-names></string-name>, <string-name><surname>Olsen</surname>
<given-names>B.</given-names></string-name>, <string-name><surname>Sjolin</surname>
<given-names>J.</given-names></string-name> and <string-name><surname>Stromstedt</surname>
<given-names>A.A.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Induction of gliotoxin secretion in <italic toggle="yes">Aspergillus fumigatus</italic> by bacteria-associated molecules</article-title>. <source>PloS ONE</source>
<volume>9</volume>, <fpage>e93685</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0093685</pub-id><?supplied-pmid 24705440?><pub-id pub-id-type="pmid">24705440</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>B.</given-names></string-name>, <string-name><surname>Forseth</surname>
<given-names>R.R.</given-names></string-name>, <string-name><surname>Bowers</surname>
<given-names>A.A.</given-names></string-name>, <string-name><surname>Schroeder</surname>
<given-names>F.C.</given-names></string-name> and <string-name><surname>Walsh</surname>
<given-names>C.T.</given-names></string-name></person-group> (<year>2012</year>) <article-title>A backup plan for self-protection: S-methylation of holomycin biosynthetic intermediates in <italic toggle="yes">Streptomyces clavuligerus</italic></article-title>. <source>ChemBioChem</source>
<volume>13</volume>, <fpage>2521</fpage>&#x02013;<lpage>2526</lpage>
<pub-id pub-id-type="doi">10.1002/cbic.201200536</pub-id><?supplied-pmid 23097183?><pub-id pub-id-type="pmid">23097183</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qin</surname>
<given-names>Z.</given-names></string-name>, <string-name><surname>Baker</surname>
<given-names>A.T.</given-names></string-name>, <string-name><surname>Raab</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>Y.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2013</year>) <article-title>The fish pathogen <italic toggle="yes">Yersinia ruckeri</italic> produces holomycin and uses an RNA methyltransferase for self-resistance</article-title>. <source>J. Biol. Chem.</source>
<volume>288</volume>, <fpage>14688</fpage>&#x02013;<lpage>14697</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112.448415</pub-id><?supplied-pmid 23572522?><pub-id pub-id-type="pmid">23572522</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Warrier</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Kapilashrami</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Argyrou</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Ioerger</surname>
<given-names>T.R.</given-names></string-name>, <string-name><surname>Little</surname>
<given-names>D.</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>K.C.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2016</year>) <article-title>N-methylation of a bactericidal compound as a resistance mechanism in <italic toggle="yes">Mycobacterium tuberculosis</italic></article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>113</volume>, <fpage>E4523</fpage>&#x02013;<lpage>E4530</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1606590113</pub-id><?supplied-pmid 27432954?><pub-id pub-id-type="pmid">27432954</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Perez-Llarena</surname>
<given-names>F.J.</given-names></string-name> and <string-name><surname>Bou</surname>
<given-names>G.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Proteomics as a tool for studying bacterial virulence and antimicrobial resistance</article-title>. <source>Front. Microbiol.</source>
<volume>7</volume>, <fpage>410</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2016.00410</pub-id><?supplied-pmid 27065974?><pub-id pub-id-type="pmid">27065974</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Newton</surname>
<given-names>G.L.</given-names></string-name>, <string-name><surname>Arnold</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Price</surname>
<given-names>M.S.</given-names></string-name>, <string-name><surname>Sherrill</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Delcardayre</surname>
<given-names>S.B.</given-names></string-name>, <string-name><surname>Aharonowitz</surname>
<given-names>Y.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>1996</year>) <article-title>Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes</article-title>. <source>J. Bacteriol.</source>
<volume>178</volume>, <fpage>1990</fpage>&#x02013;<lpage>1995</lpage>
<pub-id pub-id-type="doi">10.1128/jb.178.7.1990-1995.1996</pub-id><?supplied-pmid 8606174?><pub-id pub-id-type="pmid">8606174</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Gordon</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>I.</given-names></string-name>, <string-name><surname>Kavanagh</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Carberry</surname>
<given-names>S.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>Single-pot derivatisation strategy for enhanced gliotoxin detection by HPLC and MALDI-ToF mass spectrometry</article-title>. <source>Anal. Bioanal. Chem.</source>
<volume>401</volume>, <fpage>2519</fpage>&#x02013;<lpage>2529</lpage>
<pub-id pub-id-type="doi">10.1007/s00216-011-5344-1</pub-id><?supplied-pmid 21879298?><pub-id pub-id-type="pmid">21879298</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seo</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>Y.S.</given-names></string-name> and <string-name><surname>Yun</surname>
<given-names>C.W.</given-names></string-name></person-group> (<year>2019</year>) <article-title>The role of zinc in gliotoxin biosynthesis of <italic toggle="yes">Aspergillus fumigatus</italic></article-title>. <source>Int. J. Mol. Sci.</source>
<volume>20</volume>, <fpage>6192</fpage>
<pub-id pub-id-type="doi">10.3390/ijms20246192</pub-id><?supplied-pmid 31817957?><pub-id pub-id-type="pmid">31817957</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ye</surname>
<given-names>W.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Kong</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>W.</given-names></string-name> and <string-name><surname>Liu</surname>
<given-names>T.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Characterization of novel gliotoxin biosynthesis-related genes from deep-sea-derived fungus <italic toggle="yes">Geosmithia pallida</italic> FS140</article-title>. <source>Biochimie</source>
<volume>191</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.biochi.2021.08.001</pub-id><?supplied-pmid 34364944?><pub-id pub-id-type="pmid">34364944</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tantapakul</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Promgool</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Kanokmedhakul</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Soytong</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Hadsadee</surname>
<given-names>S.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2020</year>) <article-title>Bioactive xanthoquinodins and epipolythiodioxopiperazines from <italic toggle="yes">Chaetomium globosum</italic> 7s-1, an endophytic fungus isolated from <italic toggle="yes">Rhapis cochinchinensis</italic> (Lour.) Mart</article-title>. <source>Nat. Prod. Res.</source>
<volume>34</volume>, <fpage>494</fpage>&#x02013;<lpage>502</lpage>
<pub-id pub-id-type="doi">10.1080/14786419.2018.1489392</pub-id><?supplied-pmid 30449167?><pub-id pub-id-type="pmid">30449167</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chamilos</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>R.E.</given-names></string-name>, <string-name><surname>Lamaris</surname>
<given-names>G.A.</given-names></string-name>, <string-name><surname>Albert</surname>
<given-names>N.D.</given-names></string-name> and <string-name><surname>Kontoyiannis</surname>
<given-names>D.P.</given-names></string-name></person-group> (<year>2008</year>) <article-title>Genomewide screening for genes associated with gliotoxin resistance and sensitivity in <italic toggle="yes">Saccharomyces cerevisiae</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>52</volume>, <fpage>1325</fpage>&#x02013;<lpage>1329</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.01393-07</pub-id><?supplied-pmid 18212113?><pub-id pub-id-type="pmid">18212113</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Owens</surname>
<given-names>R.A.</given-names></string-name>, <string-name><surname>Hammel</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Sheridan</surname>
<given-names>K.J.</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G.W.</given-names></string-name> and <string-name><surname>Doyle</surname>
<given-names>S.</given-names></string-name></person-group> (<year>2014</year>) <article-title>A proteomic approach to investigating gene cluster expression and secondary metabolite functionality in <italic toggle="yes">Aspergillus fumigatus</italic></article-title>. <source>PLoS ONE</source>
<volume>9</volume>, <fpage>e106942</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0106942</pub-id><?supplied-pmid 25198175?><pub-id pub-id-type="pmid">25198175</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jones</surname>
<given-names>R.W.</given-names></string-name> and <string-name><surname>Hancock</surname>
<given-names>J.G.</given-names></string-name></person-group> (<year>1988</year>) <article-title>Mechanism of gliotoxin action and factors mediating gliotoxin sensitivity</article-title>. <source>Microbiology</source>
<volume>134</volume>, <fpage>2067</fpage>&#x02013;<lpage>2075</lpage>
<pub-id pub-id-type="doi">10.1099/00221287-134-7-2067</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karadottir</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Coorens</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Agerberth</surname>
<given-names>B.</given-names></string-name>, <string-name><surname>Giske</surname>
<given-names>C.G.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2019</year>) <article-title><italic toggle="yes">Klebsiella pneumoniae</italic> expressing VIM-1 metallo-&#x003b2;-lactamase is resensitized to cefotaxime via thiol-mediated zinc chelation</article-title>. <source>Infect. Immun.</source>
<volume>88</volume>, <fpage>e00756</fpage>&#x02013;<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.00756-19</pub-id><?supplied-pmid 31611270?><pub-id pub-id-type="pmid">31611270</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>W.</given-names></string-name>, <string-name><surname>Solis</surname>
<given-names>N.V.</given-names></string-name>, <string-name><surname>Woolford</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>A.P.</given-names></string-name> and <string-name><surname>Filler</surname>
<given-names>S.G.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Functional convergence of gliP and aspf1 in <italic toggle="yes">Aspergillus fumigatus</italic> pathogenicity</article-title>. <source>Virulence</source>
<volume>9</volume>, <fpage>1062</fpage>&#x02013;<lpage>1073</lpage>
<pub-id pub-id-type="doi">10.1080/21505594.2018.1482182</pub-id><?supplied-pmid 30052103?><pub-id pub-id-type="pmid">30052103</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname>
<given-names>B.S.</given-names></string-name>, <string-name><surname>Praveen</surname>
<given-names>B.</given-names></string-name>, <string-name><surname>Amrita</surname>
<given-names>P.</given-names></string-name>, <string-name><surname>Santosh</surname>
<given-names>B.</given-names></string-name>, <string-name><surname>Kumar</surname>
<given-names>P.K.</given-names></string-name>, <string-name><surname>Mishra</surname>
<given-names>R.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>Comparative study of various mycotoxins against few bacterial test organisms</article-title>. <source>J. Pharmaceut. Res.</source>
<volume>10</volume>, <fpage>116</fpage>&#x02013;<lpage>119</lpage>
<pub-id pub-id-type="doi">10.18579/jpcrkc/2011/10/3/89005</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname>
<given-names>W.L.</given-names></string-name>, <string-name><surname>Le</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H.J.</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>X.L.</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>J.X.</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>J.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2014</year>) <article-title>Exploring the chemodiversity and biological activities of the secondary metabolites from the marine fungus Neosartorya pseudofischeri</article-title>. <source>Mar. Drugs</source>
<volume>12</volume>, <fpage>5657</fpage>&#x02013;<lpage>5676</lpage>
<pub-id pub-id-type="doi">10.3390/md12115657</pub-id><?supplied-pmid 25421322?><pub-id pub-id-type="pmid">25421322</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>S.-K.</given-names></string-name>, <string-name><surname>Nam</surname>
<given-names>K.W.</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>J.S.</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>H.D.</given-names></string-name> and <string-name><surname>Son</surname>
<given-names>B.W.</given-names></string-name></person-group> (<year>2006</year>) <article-title>A new antibacterial dioxopiperazine alkaloid related to gliotoxin from a marine isolate of the fungus <italic toggle="yes">Pseudallescheria</italic></article-title>. <source>J. Antibiot. (Tokyo)</source>
<volume>59</volume>, <fpage>248</fpage>&#x02013;<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1038/ja.2006.35</pub-id><?supplied-pmid 16830893?><pub-id pub-id-type="pmid">16830893</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnson</surname>
<given-names>J.R.</given-names></string-name>, <string-name><surname>Bruce</surname>
<given-names>W.F.</given-names></string-name> and <string-name><surname>Dutcher</surname>
<given-names>J.D.</given-names></string-name></person-group> (<year>1943</year>) <article-title>Gliotoxin, the antibiotic principle of Gliocladium fimbriatum. I. Production, physical and biological properties</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>65</volume>, <fpage>2005</fpage>&#x02013;<lpage>2009</lpage>
<pub-id pub-id-type="doi">10.1021/ja01250a051</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feng</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>E.L.</given-names></string-name>, <string-name><surname>Hong</surname>
<given-names>J.</given-names></string-name> and <string-name><surname>Jung</surname>
<given-names>J.H.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Gliotoxin is antibacterial to drug-resistant piscine pathogens</article-title>. <source>Nat. Prod. Sci.</source>
<volume>24</volume>, <fpage>225</fpage>&#x02013;<lpage>228</lpage>
<pub-id pub-id-type="doi">10.20307/nps.2018.24.4.225</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brewer</surname>
<given-names>D.</given-names></string-name>, <string-name><surname>Hannah</surname>
<given-names>D.E.</given-names></string-name>, <string-name><surname>Rahman</surname>
<given-names>R.</given-names></string-name> and <string-name><surname>Taylor</surname>
<given-names>A.</given-names></string-name></person-group> (<year>1967</year>) <article-title>The growth of bacillus subtilis in media containing chetomin, sporidesmin, and gliotoxin</article-title>. <source>Can. J. Microbiol.</source>
<volume>13</volume>, <fpage>1451</fpage>&#x02013;<lpage>1460</lpage>
<pub-id pub-id-type="doi">10.1139/m67-193</pub-id><?supplied-pmid 4965004?><pub-id pub-id-type="pmid">4965004</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stanley</surname>
<given-names>S.A.</given-names></string-name>, <string-name><surname>Grant</surname>
<given-names>S.S.</given-names></string-name>, <string-name><surname>Kawate</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Iwase</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Shimizu</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Wivagg</surname>
<given-names>C.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2012</year>) <article-title>Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening</article-title>. <source>ACS Chem. Biol.</source>
<volume>7</volume>, <fpage>1377</fpage>&#x02013;<lpage>1384</lpage>
<pub-id pub-id-type="doi">10.1021/cb300151m</pub-id><?supplied-pmid 22577943?><pub-id pub-id-type="pmid">22577943</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luo</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J.</given-names></string-name>
<etal>et al</etal>.</person-group> (<year>2017</year>) <article-title>Antituberculosis compounds from a deep-sea-derived fungus Aspergillus sp. SCSIO Ind09F01</article-title>. <source>Nat. Prod. Res.</source>
<volume>31</volume>, <fpage>1958</fpage>&#x02013;<lpage>1962</lpage>
<pub-id pub-id-type="doi">10.1080/14786419.2016.1266353</pub-id><?supplied-pmid 28068839?><pub-id pub-id-type="pmid">28068839</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Liew</surname>
<given-names>M.</given-names></string-name> and <string-name><surname>Wang</surname>
<given-names>Y.</given-names></string-name></person-group>
<article-title>Roles of redox-active antibiotics in bacterial-fungal interactions between <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Aspergillus fumigatus</italic></article-title>, <comment><ext-link xlink:href="https://isen.northwestern.edu/sites/default/files/Booster_YWang.Mar10_ProjectSummary.pdf" ext-link-type="uri">https://isen.northwestern.edu/sites/default/files/Booster_YWang.Mar10_ProjectSummary.pdf</ext-link></comment></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pierson</surname>
<given-names>L.S.</given-names></string-name> and <string-name><surname>Pierson</surname>
<given-names>E.A.</given-names></string-name></person-group> (<year>2010</year>) <article-title>Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>86</volume>, <fpage>1659</fpage>&#x02013;<lpage>1670</lpage>
<pub-id pub-id-type="doi">10.1007/s00253-010-2509-3</pub-id><?supplied-pmid 20352425?><pub-id pub-id-type="pmid">20352425</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dietrich</surname>
<given-names>L.E.P.</given-names></string-name>, <string-name><surname>Price-Whelan</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Whiteley</surname>
<given-names>M.</given-names></string-name> and <string-name><surname>Newman</surname>
<given-names>D.K.</given-names></string-name></person-group> (<year>2006</year>) <article-title>The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title>. <source>Mol. Microbiol.</source>
<volume>61</volume>, <fpage>1308</fpage>&#x02013;<lpage>1321</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05306.x</pub-id><?supplied-pmid 16879411?><pub-id pub-id-type="pmid">16879411</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andreini</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Bertini</surname>
<given-names>I.</given-names></string-name> and <string-name><surname>Rosato</surname>
<given-names>A.</given-names></string-name></person-group> (<year>2009</year>) <article-title>Metalloproteomes: a bioinformatic approach</article-title>. <source>Acc. Chem. Res.</source>
<volume>42</volume>, <fpage>1471</fpage>&#x02013;<lpage>1479</lpage>
<pub-id pub-id-type="doi">10.1021/ar900015x</pub-id><?supplied-pmid 19697929?><pub-id pub-id-type="pmid">19697929</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Roberts</surname>
<given-names>E.</given-names></string-name> and <string-name><surname>Luthey-Schulten</surname>
<given-names>Z.</given-names></string-name></person-group> (<year>2009</year>) <article-title>Horizontal gene transfer of zinc and non-zinc forms of bacterial ribosomal protein S4</article-title>. <source>BMC Evol. Biol.</source>
<volume>9</volume>, <fpage>179</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2148-9-179</pub-id><?supplied-pmid 19640295?><pub-id pub-id-type="pmid">19640295</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Danchin</surname>
<given-names>A.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Zinc, an unexpected integrator of metabolism?</article-title>
<source>Microb. Biotechnol.</source>
<volume>13</volume>, <fpage>895</fpage>&#x02013;<lpage>898</lpage>
<pub-id pub-id-type="doi">10.1111/1751-7915.13549</pub-id><?supplied-pmid 32153121?><pub-id pub-id-type="pmid">32153121</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ye</surname>
<given-names>W.</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>T.</given-names></string-name> and <string-name><surname>Zhang</surname>
<given-names>W.</given-names></string-name></person-group> (<year>2021</year>) <article-title>The toxic mechanism of gliotoxins and biosynthetic strategies for toxicity prevention</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>22</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>
<pub-id pub-id-type="doi">10.3390/ijms222413510</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Danchin</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Sekowska</surname>
<given-names>A.</given-names></string-name> and <string-name><surname>You</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2020</year>) <article-title>One-carbon metabolism, folate, zinc and translation</article-title>. <source>Microb. Biotechnol.</source>
<volume>13</volume>, <fpage>899</fpage>&#x02013;<lpage>925</lpage>
<pub-id pub-id-type="doi">10.1111/1751-7915.13550</pub-id><?supplied-pmid 32153134?><pub-id pub-id-type="pmid">32153134</pub-id></mixed-citation></ref></ref-list></back></article>